0000000000010778

AUTHOR

Rafael Tabarés-seisdedos

showing 175 related works from this author

Additional file 2: of Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of ob…

2019

Key terms for PubMed/MEDLINE search. (DOCX 28 kb)

3. Good health
researchProduct

Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systema…

2020

Publisher's version (útgefin grein)

Index (economics)Servicios de SaludSUSTAINABLE DEVELOPMENT GOALS030204 cardiovascular system & hematologyuniversal health coverage; sustaibale develpment goal; global burden of disease; performance;universal health coveragesystematic analysisGlobal Burden of Disease0302 clinical medicineUniversal Health InsuranceRA042111. SustainabilityPer capitaMedical economicsDisease030212 general & internal medicine10. No inequality11 Medical and Health Scienceseffective coverage of health servicesGBD 2019 Universal Health Coverage Collaboratorseducation.field_of_studyPublic healthMedical careSjúkdómar4. Education1. No povertyHealth coveragePublic Health Global Health Social Medicine and EpidemiologyGeneral MedicineHälsovetenskaper3142 Public health care science environmental and occupational healthHealth services3. Good healthGlobal burden of diseaseGlobal Burden of Disease; Health Expenditures; Humans; Universal Health Insurance; World Health OrganizationPurchasing power parityScale (social sciences)/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingLýðheilsauniversal health coveragCANCER SURVIVALACCESSperformanceHumanHeilsuhagfræðimedicine.medical_specialtyHealth coverage GBDGBDUniversal healthGBD 2019Population2019Health expenditures3122 CancersPopulation healthWorld Health Organization03 medical and health sciencesHealth systemsHeilbrigðisvísindiSDG 3 - Good Health and Well-beingGeneral & Internal MedicineDevelopment economicsHealth SciencesmedicineHeilbrigðisstefnasustaibale develpment goalAlþjóðaheilbrigðisstofnuninHumansQUALITYGlobal Burden of Disease StudyeducationPROGRESSDisease burdenPublic healthHealth services accessibilityCAREHeilbrigðisþjónusta//purl.org/pe-repo/ocde/ford#3.02.00 [https]Health ExpenditureFolkhälsovetenskap global hälsa socialmedicin och epidemiologi3121 General medicine internal medicine and other clinical medicineMorbilityAdministración de los Servicios de SaludMedical policyBusinessHealth ExpendituresHeilbrigðiskerfi
researchProduct

Abnormal motor asymmetry only during bimanual movement in schizophrenic patients compared with healthy subjects.

2003

In schizophrenia, research on motor asymmetry has focused on the direction and the degree of handedness using unimanual motor tests and tasks. However, typically both hands collaborate in the production of most manual movements. This study explored motor asymmetry exhibited during unimanual and bimanual tasks in schizophrenic and healthy subjects using a new experimental motor battery. Specifically, the authors investigated the motor indices of laterality during finger-tapping and hand-turning tasks in four unimanual and four bimanual conditions in 84 schizophrenic and 31 healthy subjects, all right-handed. The schizophrenic patients showed reduced motor asymmetries only during bimanual tap…

AdultMalePsychosismedicine.medical_specialtyPsychometricsPsychometricsMotor ActivityNeuropsychological TestsLateralization of brain functionFunctional LateralityPhysical medicine and rehabilitationReference ValuesSchizophrenic PsychologymedicineHumansMotor asymmetryBiological PsychiatryBody movementmedicine.diseasePsychiatry and Mental healthSchizophreniaLateralitySchizophreniaFemaleSchizophrenic PsychologyPsychologyCognitive psychologySchizophrenia research
researchProduct

Additional file 1: of Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity diso…

2017

PRISMA-P checklist. (DOCX 24 kb)

3. Good health
researchProduct

Additional file 3: of Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic revi…

2019

Methodological Quality Checklist for Prevalence data. (DOCX 29 kb)

researchProduct

Association of Anorexia Nervosa With Risk of Cancer: A Systematic Review and Meta-analysis

2019

This systematic review and meta-analysis evaluates the association of anorexia nervosa with the cancer incidence and mortality among study populations with anorexia nervosa compared with the general population or those without anorexia nervosa.

AdultMalemedicine.medical_specialtyAnorexia NervosaPopulationbehavioral disciplines and activitiesYoung Adult03 medical and health sciences0302 clinical medicineBreast cancerNeoplasmsInternal medicineObservational studymental disordersHumansMedicine030212 general & internal medicineSex DistributionYoung adulteducationOriginal InvestigationAgedCancereducation.field_of_studybusiness.industryResearchMortality ratedigestive oral and skin physiologyCancerGeneral MedicineMiddle Agedmedicine.disease3. Good healthOnline OnlyMeta-analysisOncologyAnorexia nervosa (differential diagnoses)030220 oncology & carcinogenesisMeta-analysisSystematic reviewFemaleEpidemiologic Methodsbusinesshormones hormone substitutes and hormone antagonistsCohort study
researchProduct

Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cogn…

2011

Cognitive impairment in schizophrenia and psychosis is ubiquitous and acknowledged as a core feature of clinical expression, pathophysiology, and prediction of functioning. However, assessment of cognitive functioning is excessively time-consuming in routine practice, and brief cognitive instruments specific to psychosis would be of value. Two screening tools have recently been created to address this issue, i.e., the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP). The aim of this research was to examine the comparative validity of these two brief instruments in relation to a global cognitive score. 161 patients with p…

AdultMalemedicine.medical_specialtyPsychosisBipolar DisorderPsychometricsConcurrent validityNeuropsychological TestsPsychological researchSeverity of Illness IndexExecutive FunctionMemorymedicineHumansManic-depressive illnessAttentionBipolar disorderNeuropsychological assessmentPsychiatryBiological PsychiatryPsychiatric Status Rating ScalesTrastorn bipolarmedicine.diagnostic_testReproducibility of ResultsCognitionMiddle Agedmedicine.diseaseCognitivismePsychiatry and Mental healthROC CurveSchizophreniaCognitive remediation therapyArea Under CurveInvestigació psicològicaSchizophreniaFemaleSchizophrenic PsychologyEsquizofrèniaCognition DisordersPsychologyCognitivismClinical psychologyBrief Cognitive Assessment Tool
researchProduct

Functional impairment in bipolar II disorder: Is it as disabling as bipolar I?

2010

It is well established that patients with bipolar disorder experience functional impairment even in remission. Nevertheless, bipolar II disorder remains understudied because most investigations to date include only bipolar I patients or just a small sample of bipolar II patients, without explicitly comparing both subtypes of disorder. The main objective of the current report is to evaluate overall and multiple domains of functioning, specifically in bipolar II disorder compared to patients with bipolar I disorder and healthy subjects.233 subjects from 3 groups were compared: bipolar I patients (n=106), bipolar II patients (n=66) and healthy controls (n=61). Bipolar patients meeting criteria…

AdultMalemedicine.medical_specialtyBipolar DisorderBipolar I disorderFunctional impairmentPersonality InventoryArgentinaYoung Mania Rating ScaleDisability EvaluationBipolar II disorderRating scaleInternal medicinemental disordersmedicineHumansBipolar disorderPsychiatryDepression (differential diagnoses)DepressionCognitionMiddle Agedmedicine.diseaseHospitalizationPsychiatry and Mental healthClinical PsychologyChronic DiseaseFemalesense organsCognition DisordersPsychologyJournal of Affective Disorders
researchProduct

The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study…

2010

Abstract Background Atypical antipsychotics provide better control of the negative and affective symptoms of schizophrenia when compared with conventional neuroleptics; nevertheless, their heightened ability to improve cognitive dysfunction remains a matter of debate. This study aimed to examine the changes in cognition associated with long-term antipsychotic treatment and to evaluate the effect of the type of antipsychotic (conventional versus novel antipsychotic drugs) on cognitive performance over time. Methods In this naturalistic study, we used a comprehensive neuropsychological battery of tests to assess a sample of schizophrenia patients taking either conventional (n = 13) or novel a…

AdultMalemedicine.medical_specialtyCognition disorderslcsh:RC435-571Teràpia cognitivamedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticPilot ProjectsComorbidityCognitive therapyNeuropsychological TestsTrastorns de la cogniciólcsh:PsychiatryResearch articlemedicineHumansVerbal fluency testLongitudinal StudiesAntipsychotic drugsEffects of sleep deprivation on cognitive performancePsychiatryAntipsychoticRetrospective StudiesPsychiatric Status Rating ScalesCognitionExecutive functionsmedicine.diseasePsychiatry and Mental healthTreatment OutcomeSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyAntipsicòticsEsquizofrèniaVerbal memoryCognition DisordersPsychologyAntipsychotic AgentsClinical psychologyBMC Psychiatry
researchProduct

Diez años de investigación traslacional colaborativa en enfermedades mentales: el CIBERSAM

2019

Psychiatry and Mental healthbusiness.industryMedicinebusinessHumanitiesRevista de Psiquiatría y Salud Mental
researchProduct

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 3…

2017

Importance: Cancer is the second leading cause of death worldwide. Current estimates on the burden of cancer are needed for cancer control planning.Objective: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 32 cancers in 195 countries and territories from 1990 to 2015.Evidence Review: Cancer mortality was estimated using vital registration system data, cancer registry incidence data (transformed to mortality estimates using separately estimated mortality to incidence [MI] ratios), and verbal autopsy data. Cancer incidence was calculated by dividing mortality estimates through the modeled MI ratio…

0301 basic medicineGerontologyCancer ResearchPopulationArticle03 medical and health sciences0302 clinical medicineBreast cancerGlobal healthcancerMedicineDisability-adjusted life yeareducationDisease burdeneducation.field_of_studyestimate mortalityCancer preventioncancer preventionbusiness.industryMortality rate1. No povertymedicine.disease3. Good health030104 developmental biologyYears of potential life lostOncology030220 oncology & carcinogenesisbusinessearly diagnosisDemography
researchProduct

Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Este es el artículo que se ha publicado de forma definitiva en: https://molecularautism.biomedcentral.com/articles/10.1186/s13229-019-0262-8 En este artículo también participa Joan Climent, Vera Pancaldi, Lourdes Fañanás, Celso Arango, Mara Parellada, Anaïs Baudot, Daniel Vogt, John L. Rubenstein, Alfonso Valencia y Rafael Tabarés-Seisdedos. Background: Epidemiological and clinical evidence points to cancer as a comorbidity in people with autism spectrum disorders (ASD). A significant overlap of genes and biological processes between both diseases has also been reported. Methods: Here, for the first time, we compared the gene expression profiles of ASD frontal cortex tissues and 22 cancer t…

Autism.AutismComorbidityBioinformaticsAutismo.lcsh:RC346-429Expresión génica.TranscriptomeAfectividad - Trastornos.0302 clinical medicineNeoplasmsGene expression2.1 Biological and endogenous factorsAetiologyCàncerCáncer - Aspectos genéticos.ComputingMilieux_MISCELLANEOUSCancer0303 health sciencesProstate CancerBrainAffective disorders.3. Good healthPsychiatry and Mental healthMental HealthSignal transductionSignal TransductionBiotechnologyUrologic DiseasesIntellectual and Developmental Disabilities (IDD)1.1 Normal biological development and functioningClinical SciencesBiologyASDBiological pathway03 medical and health sciencesDevelopmental NeuroscienceUnderpinning researchmental disordersGeneticsmedicineHumansAutistic DisorderIntellectual and Developmental DisabilitiesGeneMolecular Biologylcsh:Neurology. Diseases of the nervous systemPI3K/AKT/mTOR pathwayCancer - Genetic aspects.030304 developmental biologyResearchNeurosciencesMultimorbidityCancermedicine.diseaseExpressió gènicaHuman geneticsBrain DisordersMeta-analysisGene expression.AutismGene expressionAutisme[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM]TranscriptomeKidney cancer030217 neurology & neurosurgeryDevelopmental BiologyMolecular Autism
researchProduct

Neurocognitive impairment and psychosocial functioning in bipolar II disorder

2011

Sole B, Bonnin CM, Torrent C, Balanza-Martinez V, Tabares-Seisdedos R, Popovic D, Martinez-Aran A, Vieta E. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Objective:  There is a growing body of evidence on neurocognitive impairment in euthymic bipolar patients, but this issue has been studied mostly in bipolar I disorder, data on bipolar II (BD-II) are scant and discrepant. The two aims of this study were to ascertain whether strictly defined euthymic BD-II patients would present neurocognitive disturbances and to evaluate their impact on functional outcome. Method:  Forty-three BD-II patients and 42 demographically and educationally matched healthy subjects …

medicine.medical_specialtyBipolar I disorderTrail Making TestHamilton Rating Scale for DepressionVerbal learningmedicine.diseaseYoung Mania Rating ScalePsychiatry and Mental healthBipolar II disorderHypomaniamedicinemedicine.symptomPsychologyPsychiatryNeurocognitiveActa Psychiatrica Scandinavica
researchProduct

Functional outcome in bipolar disorder: the role of clinical and cognitive factors.

2007

Introduction:  Few studies have examined the clinical, neuropsychological and pharmacological factors involved in the functional outcome of bipolar disorder despite the gap between clinical and functional recovery. Methods:  A sample of 77 euthymic bipolar patients were included in the study. Using an a priori definition of low versus good functional outcome, based on the psychosocial items of the Global Assessment of Functioning (GAF, DSM-IV), and taking also into account their occupational adaptation, the patients were divided into two groups: good or low occupational functioning. Patients with high (n = 46) and low (n = 31) functioning were compared on several clinical, neuropsychologica…

AdultEmploymentMalemedicine.medical_specialtyBipolar DisorderGlobal Assessment of FunctioningNeuropsychological TestsSeverity of Illness IndexAdaptation PsychologicalmedicineHumansPsychologyBipolar disorderEffects of sleep deprivation on cognitive performancePsychiatryBiological PsychiatryDemographyNeuropsychologyCognitionmedicine.diseaseExecutive functionsAntidepressive AgentsDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthFemaleVerbal memoryPsychologyCognition DisordersPsychosocialSocial AdjustmentClinical psychologyAntipsychotic AgentsBipolar disorders
researchProduct

Long-Term Outcome of Cognitive Impairment in Bipolar Disorder

2011

OBJECTIVE: To evaluate the longitudinal course and outcome of cognitive deficits and their clinical correlates in bipolar disorder. METHOD: One hundred thirteen participants (68 patients and 45 healthy controls) were assessed by the means of a neuropsychological battery targeting attention, psychomotor speed, verbal memory, and executive functions at baseline: 68 euthymic outpatients with a DSM-IV diagnosis of bipolar disorder (53 bipolar I and 15 bipolar II) were enrolled at the Bipolar Disorder Unit of the Hospital Clinic of Barcelona. Forty-five patients completed the follow-up. The assessments started in February 1999 and finished in July 2010. The primary outcome of the study was the c…

AdultMalemedicine.medical_specialtyBipolar DisorderPsychometricsPsychometricsNeuropsychological TestsExecutive FunctionmedicineHumansBipolar disorderPsychomotor learningWechsler ScalesNeuropsychologyWechsler Adult Intelligence ScaleCognitionMiddle Agedmedicine.diseaseExecutive functionsPsychiatry and Mental healthDisease ProgressionPhysical therapyFemaleVerbal memoryCognition DisordersPsychologyFollow-Up StudiesClinical psychologyThe Journal of Clinical Psychiatry
researchProduct

Therapeutic use of omega-3 fatty acids in bipolar disorder

2011

Bipolar disorder (BD) is a severe, chronic affective disorder, associated with significant disability, morbidity and premature mortality. Omega-3 polyunsaturated fatty acids (PUFAs) play several important roles in brain development and functioning. Evidence from animal models of dietary omega-3 (n-3) PUFA deficiency suggest that these fatty acids are relevant to promote brain development and to regulate behavioral and neurochemical aspects related to mood disorders, such as stress responses, depression and aggression, as well as dopaminergic content and function. Preclinical and clinical evidence suggests roles for PUFAs in BD. n-3 PUFAs seem to be an effective adjunctive treatment for unip…

chemistry.chemical_classificationBipolar Disordermedicine.drug_classBrain-Derived Neurotrophic FactorGeneral NeuroscienceDopaminergicMood stabilizerBioinformaticsmedicine.diseaseNeuroprotectionNeuroprotective AgentsNeurochemicalMood disorderschemistryFatty Acids Omega-3Adjunctive treatmentmedicineAnimalsHumansPharmacology (medical)Neurology (clinical)Bipolar disorderPsychologyClinical psychologyPolyunsaturated fatty acidExpert Review of Neurotherapeutics
researchProduct

Bipolar I patients with and without a history of psychotic symptoms: do they differ in their cognitive functioning?

2007

Abstract Recently, many reports have consistently demonstrated cognitive deficits in patients with bipolar disorder (BD), but their relationship with symptomatology, specifically psychotic symptoms, remains unclear. Our main hypothesis was that a history of hallucinations and/or delusions in the course of BD-I is associated with severe cognitive deficits. We investigated several cognitive functions (memory, attention, verbal fluency and executive functions) in 18 BD-I patients with a history of psychotic symptoms (HPS+), 17 BD-I patients without a history of psychotic symptoms (HPS−), 33 schizophrenic patients and 26 healthy control subjects. Both groups of BD-I patients were more impaired …

AdultMalemedicine.medical_specialtyPsychosisBipolar I disorderBipolar DisorderAdolescentNeuropsychological TestsCognitionmedicineVerbal fluency testHumansBipolar disorderPsychiatryBiological PsychiatryAgedPsychiatric Status Rating ScalesAnalysis of VarianceMental DisordersCognitive disorderMiddle Agedmedicine.diseaseExecutive functionsPsychiatry and Mental healthSchizophreniaSchizophreniaFemaleVerbal memoryPsychologyClinical psychologyJournal of psychiatric research
researchProduct

High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment

2017

BackgroundCognitive reserve (CR) reflects the capacity of the brain to endure neuropathology, minimize clinical manifestations and successfully complete cognitive tasks. The present study aims to determine whether high CR may constitute a moderator of cognitive functioning in bipolar disorder (BD).MethodsOne hundred and two patients with BD and 32 healthy controls were enrolled. All patients met DSM-IV criteria for I or II BD and were euthymic (YMRS ≤ 6 and HDRS ≤ 8) during a 6-month period. All participants were tested with a comprehensive neuropsychological battery, and a Cerebral Reserve Score (CRS) was estimated. Subjects with a CRS below the group median were classified as having low C…

AdultMalemedicine.medical_specialtyElementary cognitive taskBipolar DisorderBipolar disorderCognitive reserveNeuropsychological TestsAudiologyYoung Adult03 medical and health sciences0302 clinical medicineCognitive ReservemedicineHumansVerbal fluency testCognitive skillBipolar disorderPsychiatryNeurocognitionCognitive reserveCalifornia Verbal Learning TestBipolar disorder Cognitive heterogeneity Cognitive reserve NeurocognitionMiddle Agedmedicine.diseaseCyclothymic Disorder030227 psychiatryDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesCognitive remediation therapyFemaleCuesVerbal memoryCognition DisordersPsychologyNeurocognitive030217 neurology & neurosurgeryCognitive heterogeneityJournal of Affective Disorders
researchProduct

Staging, neurocognition and social functioning in bipolar disorder.

2018

Introduction: Bipolar disorder (BD) is associated with significant neurocognitive and functional impairment, which may progress across stages. The ‘latent stage' of BD remains understudied. This cross-sectional study assessed staging, neurocognition and social functioning among BD patients and their healthy siblings.Methods: Four groups were included: euthymic type I BD patients in the early (n = 25) and late (n = 23) stages, their healthy siblings (latent stage; n = 23) and healthy controls (n = 21). All 92 subjects underwent a comprehensive neuropsychological battery of processing speed, verbal learning/memory, visual memory, working memory, verbal fluency, executive cognition, and motor …

lcsh:RC435-571Bipolar disorderFenótiponeurocognitionVerbal learningfirst-degree relativesfunctioning03 medical and health sciencesNeurologia0302 clinical medicineVisual memorylcsh:Psychiatryclinical stagingmedicineMemóriaVerbal fluency testFirst-degree relativesFunctioningBipolar disorderNeurocognitionsiblingsOriginal ResearchPsychiatrybipolar disorderWorking memorybusiness.industrySiblingsTranstorno bipolarIrmãosCognitionmedicine.disease030227 psychiatryPsychiatry and Mental healthClinical stagingVerbal memorybusinessMalalties mentalsNeurocognitiveCogniçãoProgressão da doença030217 neurology & neurosurgeryClinical psychology
researchProduct

Grip Strength, Neurocognition, and Social Functioning in People WithType-2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizo…

2020

[Background] Frailty is a common syndrome among older adults and patients with several comorbidities. Grip strength (GS) is a representative parameter of frailty because it is a valid indicator of current and long-term physical conditions in the general population and patients with severe mental illnesses (SMIs). Physical and cognitive capacities of people with SMIs are usually impaired; however, their relationship with frailty or social functioning have not been studied to date. The current study aimed to determine if GS is a valid predictor of changes in cognitive performance and social functioning in patients with type-2 diabetes mellitus and SMIs.

:Psychiatry and Psychology::Mental Disorders::Mood Disorders::Affective Disorders Psychotic::Bipolar Disorder [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]0302 clinical medicine:Psychiatry and Psychology::Mental Disorders::Mood Disorders::Depressive Disorder::Depressive Disorder Major [Medical Subject Headings]Social functioningPsychology030212 general & internal medicineType-2 diabetes mellitusCognitive performancecognitive performanceGeneral PsychologyOriginal Research:Persons::Persons::Age Groups::Adult::Aged [Medical Subject Headings]:Persons::Persons::Patients::Outpatients [Medical Subject Headings]education.field_of_studyFrailtyCognition:Disciplines and Occupations::Natural Science Disciplines::Physics::Electronics [Medical Subject Headings]Type-2 diabetesmellitusFragilidadDiabetes mellitus tipo 2SchizophreniaTrastornos mentalesMajor depressive disorder:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus::Diabetes Mellitus Type 2 [Medical Subject Headings]PsychologyClinical psychologyFuerza de la manoPopulationlcsh:BF1-990frailty03 medical and health sciencessevere mental illness:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Follow-Up Studies [Medical Subject Headings]Severe mental illnessmedicine:Psychiatry and Psychology::Mental Disorders::Schizophrenia and Disorders with Psychotic Features::Schizophrenia [Medical Subject Headings]Effects of sleep deprivation on cognitive performanceBipolar disordereducation:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Regression Analysis [Medical Subject Headings]:Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Cognition [Medical Subject Headings]:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Muscle Strength::Hand Strength [Medical Subject Headings]Type 2 Diabetes Mellitustype-2 diabetes mellitusmedicine.diseasesocial functioninglcsh:PsychologyGrip strengthgrip strengthInteracción socialNeurocognitive:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Analysis of Variance [Medical Subject Headings]030217 neurology & neurosurgeryFrontiers in Psychology
researchProduct

Additional file 3: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

Definitions of specific cancer-site outcomes. (DOCX 27 kb)

3. Good health
researchProduct

The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year …

2013

Real-world functional deficits are common and persistent in individuals with psychosis. Cognitive deficits have been shown to compromise functioning. We aimed to study the predictive values of premorbid, sociodemographic, and baseline clinical and neurocognitive factors on long-term functional outcome for individuals with first episode non-affective psychosis. We failed to demonstrate a significant relationship between cognitive deficits at baseline and functional disability at 3 year follow-up. Diagnosis of schizophrenia (OR=2.457, p=0.011), shorter education (OR=1.177, p=0.005) and poor premorbid social adjustment (OR=1.628, p=0.013) emerged as the strongest predictors for the 114 subject…

AdultMalePsychosismedicine.medical_specialtyLongitudinal studyAdolescentNeuropsychological TestsOutcome (game theory)Disability EvaluationYoung AdultPredictive Value of TestsmedicineHumansLongitudinal StudiesPsychiatryBiological PsychiatryRetrospective StudiesFirst episodeCognitionMiddle AgedPrognosismedicine.diseasePsychiatry and Mental healthLogistic ModelsPsychotic DisordersSocioeconomic FactorsSchizophreniaFemaleCognition DisordersPsychologyNeurocognitiveAntipsychotic AgentsDiagnosis of schizophreniaPsychiatry Research
researchProduct

Additional file 2: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

Key terms for PubMed/MEDLINE search. (DOCX 22 kb)

3. Good health
researchProduct

Additional file 2: of Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of ob…

2019

Key terms for PubMed/MEDLINE search. (DOCX 28 kb)

3. Good health
researchProduct

Human adult periodontal ligament-derived cells integrate and differentiate after implantation into the adult mammalian brain.

2013

Previous studies suggest that neural crest (NC)-derived stem cells may reside in NC derivatives including the human periodontal ligament (hPDL). The isolation and manipulation of autologous NC-derived cells could be an accessible source of adult neural stem cells for their use in cell replacement and gene transfer to the diseased central nervous system. In this study, we examined the expression of NC markers and neural differentiation potential of hPDL-derived cells both in vitro and in vivo. In vitro we found that hPDL-derived cells expressed stem cell markers (Oct3/4, Nestin, Sox2, and Musashi-1) and a subset of NC cell markers (Slug, p75(NTR), Twist, and Sox9). hPDL-derived cells differe…

Doublecortin ProteinPeriodontal LigamentCellular differentiationTransplantation HeterologousBiomedical Engineeringlcsh:MedicineSubventricular zoneMice NudeBiologyStem cell markerHippocampusSubgranular zoneMiceSOX2Cell MovementmedicineAnimalsHumansStem Cell NicheCells CulturedNeuronsTransplantationStem Cellslcsh:RNeural crestBrainCell DifferentiationCell BiologyAnatomyNeural stem cellCell biologymedicine.anatomical_structurenervous systemStem cellBiomarkersStem Cell TransplantationCell transplantation
researchProduct

Neurocognitive Impairment in Bipolar Patients With and Without History of Psychosis

2008

Objective: Little is known regarding the impact of psychotic symptoms on the cognitive functioning of bipolar patients. Findings from previous reports are controversial and mainly focused on current psychotic symptoms. The main aim of this study was to ascertain whether the history of psychotic symptoms was associated with greater cognitive impairment in euthymic bipolar patients. Method: Sixty-five euthymic bipolar disorder patients (DSM-IV criteria; 35 with a history of psychotic symptoms and 30 without such a history) were assessed through a neuropsychological battery targeting attention, psychomotor speed, verbal memory, and executive functions. Thirty-five healthy controls were also in…

AdultMalemedicine.medical_specialtyPsychosisBipolar DisorderNeuropsychological TestsMemorymedicineHumansAttentionMedical historyBipolar disorderMedical History TakingPsychiatryMemory DisordersCognitive disorderNeuropsychologyMiddle AgedVerbal Learningmedicine.diseaseExecutive functionsPsychiatry and Mental healthPsychotic DisordersResearch DesignCase-Control StudiesFemaleVerbal memoryCognition DisordersPsychologyNeurocognitiveClinical psychologyThe Journal of Clinical Psychiatry
researchProduct

Developmental dynamics of PAFAH1B subunits during mouse brain development.

2012

Platelet-activating factor (PAF) mediates an array of biological processes in the mammalian central nervous system as a bioactive lipid messenger in synaptic function and dysfunction (plasticity, memory, and neurodegeneration). The intracellular enzyme that deacetylates the PAF (PAFAH1B) is composed of a tetramer of two catalytic subunits, ALPHA1 (PAFAH1B3) and ALPHA2 (PAFAH1B2), and a regulatory dimer of LIS1 (PAFAH1B1). We have investigated the mouse PAFAH1B subunit genes during brain development in normal mice and in mice with a hypomorphic allele for Lis1 (Lis1/sLis1; Cahana et al. [2001] Proc Natl Acad Sci U S A 98:6429–6434). We have analyzed quantitatively (by means of real-time poly…

Transcription GeneticProtein subunitNeurogenesisCentral nervous systemHindbrainIn situ hybridizationBiologyReal-Time Polymerase Chain Reaction03 medical and health sciencesMice0302 clinical medicineGene expressionmedicineAnimalsIn Situ Hybridization030304 developmental biologyRegulation of gene expression0303 health sciencesCerebrumGeneral NeuroscienceBrainGene Expression Regulation DevelopmentalMolecular biologyImmunohistochemistry3. Good healthMice Inbred C57BLProtein Subunitsmedicine.anatomical_structureForebrain1-Alkyl-2-acetylglycerophosphocholine EsteraseTranscriptomeMicrotubule-Associated Proteins030217 neurology & neurosurgery
researchProduct

The prevalence of bipolar disorders in the general population - a growing trending topic?

2015

report the first meta-analysis of theprevalence of bipolar disorder (BD) from population-based studies. Strengths of the manuscript include theuse of suitable methods of analysis, reporting both annualand lifetime prevalence rates, and providing separatedata for bipolar subtypes I and II. The latter is relevantbecause type II is not simply a milder or minor form of BD.This publication is of considerable interest, firstlybecause it confirms that the frequency of BD in thegeneral population is low and closer to the conservativeestimates of 1-2%, as suggested by historical data.

medicine.medical_specialtyeducation.field_of_studyBipolar Disorderlcsh:RC435-571PopulationLifetime prevalencemedicine.diseasePsychiatry and Mental healthlcsh:PsychiatrymedicineHumansBipolar disorderPsiquiatriaPsychiatryeducationPsychology
researchProduct

The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Dis…

2022

Artículo escrito por un elevado número de autores, solo se referencian el que aparece en primer lugar, el nombre del grupo de colaboración, si le hubiere, y los autores pertenecientes a la UAM

MedicinaRJ101Mental disordersSubstance use3121 Internal medicineEurope; Mental disorders; Mental health; Self-harm; Substance use; Young peopleCHILDRJ101 Child Health. Child health servicesSDG 3 - Good Health and Well-beingSYSTEMATIC ANALYSISInternal MedicineSelf-harmPublic Environmental & Occupational HealthRISKMCCScience & TechnologyHealth PolicyYoung people; Mental health; Mental disorders; Self-harm; Substance use; EuropeDAS3142 Public health care science environmental and occupational healthPREVALENCEEuropeMental disorderHealth Care Sciences & ServicesOncologyMental healthYoung peopleHEALTHLife Sciences & BiomedicineThe Lancet Regional Health - Europe
researchProduct

Inverse Comorbidity: The Power of Paradox in the Advancement of Science

2013

Abstract: Research on comorbidity and multimorbidity is finally receiving the attention it deserves, particularly considering the magnitude and impact they have on health and the delivery of healthcare [1,2]. Numerous studies have demonstrated that individuals with Down’s syndrome, Parkinson’s disease, schizophrenia, diabetes, anorexia nervosa, Alzheimer’s disease, allergy related diseases, multiple sclerosis or Huntington’s disease (among other health problems) are protected against many forms of cancer, including solid tumors, smoking-related tumors and prostate cancer. This apparent anti-cancer effect, which we have termed inverse cancer comorbidity, has been obse…

medicine.medical_specialtymultimorbiditybusiness.industryMultiple sclerosislcsh:RCancerlcsh:MedicineDiseasemedicine.diseaseComorbidityProstate cancercomorbidityinverse comorbidityEditorialAnorexia nervosa (differential diagnoses)SchizophreniaDiabetes mellitusmental disordersmedicinedisease protectionbusinessPsychiatryJournal of Comorbidity
researchProduct

Additional file 1: of Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of ob…

2019

PRISMA-P Checklist. (DOCX 32 kb)

researchProduct

Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review.

2008

Abstract Background There is growing interest to research neurocognition as a putative endophenotype for subjects with bipolar disorders (BD). The authors sought to review the available literature focused on relatives of subjects with bipolar disorder (BD-Rels) and identify suitable cognitive candidates to endophenotypes or endophenocognitypes. Method A systematic review was conducted in Medline, EMBASE and PsycINFO databases (1980–July 2007), supplemented with a manual search of reference lists. Results Twenty-three cross-sectional papers of discordant twins (4 studies), genetic high-risk subjects (7), and different BD-Rel groups (12) met the inclusion criteria and evaluated 532 BD-Rels. I…

Psychomotor learningFamily Healthmedicine.medical_specialtyBipolar DisorderWorking memoryCognitive NeuroscienceCognitive flexibilityNeuropsychologyCognitionNeuropsychological TestsVerbal learningBehavioral NeuroscienceNeuropsychology and Physiological PsychologyCognitionmedicineDiseases in TwinsVerbal fluency testHumansFamilyPsychiatryPsychologyCognition DisordersNeurocognitiveClinical psychologyNeuroscience and biobehavioral reviews
researchProduct

The clinical implications of cognitive impairment and allostatic load in bipolar disorder.

2011

AbstractBackgroundAllostatic load (AL) relates to the neural and bodily “wear and tear” that emerge in the context of chronic stress. This paper aims to provide clinicians with a comprehensive overview of the role of AL in patophysiology of bipolar disorder (BD) and its practical implications.MethodsPubMed searches were conducted on English-language articles published from 1970 to June 2011 using the search terms allostatic load, oxidative stress, staging, and bipolar disorder cross-referenced with cognitive impairment, comorbidity, mediators, prevention.ResultsProgressive neural and physical dysfunction consequent to mood episodes in BD can be construed as a cumulative state of AL. The con…

medicine.medical_specialtyBipolar DisorderNeuropsychologyAllostasismedicine.diseaseComorbidityAllostatic loadPsychiatry and Mental healthMoodAllostasismedicineHumansBipolar disorderCognitive declinemedicine.symptomPsychiatryPsychologyCognition DisordersManiaClinical psychologyEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

Is processing speed a valid neurocognitive endophenotype in bipolar disorder? Evidence from a longitudinal, family study.

2021

[Background] Substantial evidence supports the existence of neurocognitive endophenotypes in bipolar disorder (BD), but very few longitudinal studies have included unaffected relatives. In a 5-year, follow-up, family study, we have recently suggested that deficits in manual motor speed and visual memory could be endophenotype candidates for BD. We aimed to explore whether this also applies to processing speed.

Longitudinal studyEndophenotypesBipolar disorderNeuropsychological TestsCognitionVisual memoryHumansMedicineLongitudinal StudiesBipolar disorderBiological Psychiatrybusiness.industryCognitionmedicine.diseaseFamily studyPsychiatry and Mental healthEndophenotypeMoodEndophenotypeDigit symbol substitution testLongitudinal studyCognition DisordersbusinessProcessing speedNeurocognitiveClinical psychology
researchProduct

Predicting relapse after a first episode of non-affective psychosis: A three-year follow-up study

2011

Preventing relapse during the first years of illness has a critical impact on lifelong outcomes in schizophrenia. A better understanding and improvement in factors which influence relapse should diminish the risk of relapse and consequently improve the outcome of the illness.To identify factors associated with relapse after 3 years of a first episode in a sample of non-affective psychosis patients who are representative of clinical practice in an epidemiological catchment.We analyzed socio-demographic and clinical data from a cohort of patients who were treated in a specialized early intervention service and who were at risk of relapse during a 3-year follow-up. Univariate analyses, logisti…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentYoung AdultCatchment Area HealthPredictive Value of TestsInternal medicineEpidemiologySecondary PreventionmedicineHumansLongitudinal StudiesFamily historyPsychiatryBiological PsychiatryProportional Hazards ModelsRetrospective StudiesPsychiatric Status Rating ScalesFirst episodeUnivariate analysisProportional hazards modelHazard ratioRetrospective cohort studyMiddle AgedSurvival AnalysisPsychiatry and Mental healthLogistic ModelsPsychotic DisordersCohortFemalePsychologyAntipsychotic AgentsJournal of Psychiatric Research
researchProduct

Additional file 3: of Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of…

2017

Definitions of specific cancer-site outcomes (DOCX 26 kb)

3. Good health
researchProduct

Similar effect of family history of psychosis on Sylvian fissure size and auditory P200 amplitude in schizophrenic and bipolar subjects.

2001

Several cerebral studies point to the non-specificity of structural and functional changes described in schizophrenia and bipolar disorders. Furthermore, the origin of these changes is still unclear. The present study investigated the effect of a family history (FH) of psychotic disorders in first-degree relatives on computed tomographic (CT) measures (ventricular, cerebral and Sylvian fissure size) and auditory event-related potentials (amplitudes and latencies of peak components in oddball paradigms) in 30 schizophrenic patients and 24 bipolar type I patients. We found a significant correlation between FH and the size of the right Sylvian fissure, and between FH and auditory P200 amplitud…

AdultMalemedicine.medical_specialtyPsychosisBipolar I disorderBipolar DisorderAdolescentNeuroscience (miscellaneous)AudiologymedicineHumansRadiology Nuclear Medicine and imagingFamilyBipolar disorderFamily historyFirst-degree relativesLateral sulcusMiddle Agedmedicine.diseaseTemporal LobePsychiatry and Mental healthPsychotic DisordersSchizophreniaLateralityEvoked Potentials AuditorySchizophreniaFemalesense organsPsychologyTomography X-Ray ComputedNeurosciencePsychiatry research
researchProduct

Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of observational studies

2019

[Background] Autism spectrum disorder (ASD) is a complex developmental disorder characterised by impaired social interaction and communication, and restrictive and repetitive behaviour. Previous systematic reviews have traditionally assessed the prevalence of ASD on global or regional context, with very few meta-analyses at the country level. The objective of this study will be to systematically evaluate published and unpublished observational studies that present prevalence and comorbidity of ASD among children, adolescent and adult population in Spain.

GerontologyAdultAdolescentgenetic structuresEpidemiological studyAutism Spectrum DisorderPopulationMEDLINElcsh:MedicineMedicine (miscellaneous)PsycINFOComorbiditybehavioral disciplines and activities03 medical and health sciencesYoung Adult0302 clinical medicinemental disordersmedicineProtocolPrevalenceHumans030212 general & internal medicineAutism spectrum disordereducationChildeducation.field_of_studybusiness.industry030503 health policy & serviceslcsh:Rmedicine.diseaseComorbidity3. Good healthObservational Studies as TopicMeta-analysisSystematic reviewAutism spectrum disorderSpainMeta-analysisSystematic reviewObservational study0305 other medical sciencebusiness
researchProduct

Evidence for association between structural variants in lissencephaly-related genes and executive deficits in schizophrenia or bipolar patients from …

2008

There is evidence for an association between structural variants in genes for lissencephaly, which are involved in neuronal migration, and prefrontal cognitive deficits in schizophrenia and bipolar patients. On the basis of these intriguing findings, we analyzed 16 markers located in the lissencephaly critical region (LCR in chromosome 17p13.3) in 124 schizophrenic, 56 bipolar, and 141 healthy individuals. All recruits were from a Spanish population isolate of Basque origin that is characterized by low genetic heterogeneity. In addition, we examined whether structural genomic variations in the LCR were associated with executive cognition. Twenty-three patients (12.8%), but none of the contr…

AdultMalemedicine.medical_specialtyBipolar DisorderPopulationSalud mentalLissencephalyNeuropsychological TestsPolymorphism Single NucleotideGeneticsmedicineHumansPsychiatryeducationAssociation (psychology)Biological PsychiatryGenetics (clinical)education.field_of_studyReverse Transcriptase Polymerase Chain ReactionMiddle Agedmedicine.diseasePsychiatry and Mental healthSchizophreniaSpainCase-Control StudiesSchizophreniaChristian ministryFemalePsychologyLissencephalyClinical psychologyPsychiatric genetics
researchProduct

Treatment nonadherence and neurocognitive impairment in bipolar disorder.

2009

OBJECTIVE: Little is known regarding the relationship between treatment adherence and residual cognitive dysfunction in euthymic bipolar disorder patients. This study aimed to investigate whether poor treatment adherence is associated with cognitive impairment in euthymic bipolar patients and whether other factors may be associated with both adherence and cognitive functioning. METHOD: Euthymic DSM-IV bipolar I or II disorder patients (N = 103: 61 with high levels of treatment adherence and 42 with poor treatment adherence) were assessed using a neuropsychological battery targeting attention, psychomotor speed, verbal memory, and executive functions and compared with 35 healthy controls of …

AdultMalemedicine.medical_specialtyBipolar DisorderComorbidityNeuropsychological TestsYoung Mania Rating ScaleVerbal learningSeverity of Illness IndexMemorymedicineHumansBipolar disorderPsychiatryPsychiatric Status Rating ScalesCognitive disorderHamilton Rating Scale for DepressionVerbal Learningmedicine.diseaseExecutive functionsDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthPatient ComplianceFemaleVerbal memoryPsychologyCognition DisordersLithium ChlorideNeurocognitivePsychomotor PerformanceClinical psychologyThe Journal of clinical psychiatry
researchProduct

MOESM2 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 2. Data extraction and normalisation processes.

TheoryofComputation_MATHEMATICALLOGICANDFORMALLANGUAGESComputingMethodologies_SYMBOLICANDALGEBRAICMANIPULATIONData_FILES3. Good health
researchProduct

Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17

2020

Background: Oral rehydration solution (ORS) is a form of oral rehydration therapy (ORT) for diarrhoea that has the potential to drastically reduce child mortality; yet, according to UNICEF estimates, less than half of children younger than 5 years with diarrhoea in low-income and middle-income countries (LMICs) received ORS in 2016. A variety of recommended home fluids (RHF) exist as alternative forms of ORT; however, it is unclear whether RHF prevent child mortality. Previous studies have shown considerable variation between countries in ORS and RHF use, but subnational variation is unknown. This study aims to produce high-resolution geospatial estimates of relative and absolute coverage o…

RJ101medicine.medical_treatmentCHILDRENZINC0302 clinical medicine030212 general & internal medicinemedia_commonGeographylcsh:Public aspects of medicine1. No povertyLow income and middle income countriesGeneral Medicine3142 Public health care science environmental and occupational health3. Good healthPeer reviewGeographyChild PreschoolA990 Medicine and Dentistry not elsewhere classifiedGeographical inequalities0605 MicrobiologyDiarrheaAFRICAInequalityDEATHSmedia_common.quotation_subject030231 tropical medicineDeveloping countryArticleRS1117 Public Health and Health Services03 medical and health sciencesMORBIDITYEnvironmental healthDIARRHEAL DISEASEmedicineHumansOral rehydration therapyHealthcare DisparitiesDeveloping CountriesModels StatisticalCHOLERAMORTALITYInfant NewbornInfantlcsh:RA1-1270Bayes TheoremMiddle incomeGLOBAL BURDENChild mortality0605 Microbiology 1117 Public Health and Health ServicesHealth Care SurveysITC-ISI-JOURNAL-ARTICLEFluid TherapyNAHuman medicineITC-GOLD
researchProduct

MOESM3 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 3. Reporting checklist.

3. Good health
researchProduct

NORMATIVE DATA OF THE SCIP-S IN SCHIZOPHRENIA AND TYPE I BIPOLAR DISORDER

2010

Psychiatry and Mental healthSchizophrenia (object-oriented programming)medicineNormativeBipolar disordermedicine.diseasePsychologyBiological PsychiatryClinical psychology
researchProduct

Mapping of global scientific research in comorbidity and multimorbidity: A cross-sectional analysis

2018

[Background]: The management of comorbidity and multimorbidity poses major challenges to health services around the world. Analysis of scientific research in comorbidity and multimorbidity is limited in the biomedical literature. This study aimed to map global scientific research in comorbidity and multimorbidity to understand the maturity and growth of the area during the past decades. [Methods and findings]: This was a cross-sectional analysis of the Web of Science. Searches were run from inception until November 8, 2016. We included research articles or reviews with no restrictions by language or publication date. Data abstraction was done by one researcher. A process of standardization …

Cross-sectional studylcsh:MedicineComorbidity030204 cardiovascular system & hematologyGeographical locations0302 clinical medicineEndocrinologyCitation analysisMedicine and Health Sciences030212 general & internal medicinelcsh:ScienceGeriatricsMultidisciplinaryDepressionHealth services researchResearch AssessmentPatologia3. Good healthCitation AnalysisHealth Services ResearchPsychologyResearch Articlemedicine.medical_specialtyEndocrine DisordersSpecialtyMEDLINEImpacteResearch and Analysis Methods03 medical and health sciencesBibliometriamental disordersMental Health and PsychiatrymedicineDiabetes MellitusHumansMood DisordersResearchlcsh:Rmedicine.diseaseComorbidityUnited StatesHealth CareCross-Sectional StudiesGeriatricsFamily medicineNational Comorbidity SurveyMetabolic DisordersNorth Americalcsh:QPeople and placesPLoS ONE
researchProduct

Additional file 1: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Table S1. Datasets included in our study. Table S2. Age, gender and pmi distributions between cases and control samples at each step of the preprocessing procedure at the asd defferentail gene expression meta-analysis. Table S3. Final samples included in the asd meta-analysis. Table S4. Jointly same direction derregulated genes in asd ans sddcs and jointly oposite direction derregulated genes in asd and oddcs. Table S5. Genes jointly deregulated in asd and in sddcs and oddcs. Figure S1. Comaprison of differential gene expression analysis using limma with rlog transformed data and two state of the art rnaseq differential expression metdos. Figure S2. Patient overlap in the three asd studies.…

mental disorders
researchProduct

Additional file 2: of Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic revi…

2019

Key terms for PubMed/MEDLINE search. (DOCX 29 kb)

researchProduct

Specific executive/attentional deficits in patients with schizophrenia or bipolar disorder who have a positive family history of psychosis

2003

Neurocognitive impairments are well documented in patients with schizophrenia and their healthy first-degree biological relatives. Less is known about neuropsychological performance in bipolar disorders, but some studies indicate that, compared to schizophrenia, bipolar disorder displays a similar profile pattern with less severe deficits. The genetic and environmental contributions to the development of neurocognitive deficits are also unclear. This study explored the effect of a family history (FH) of psychotic disorders in first-degree relatives on a variety of cognitive domains (abstraction and flexibility, verbal fluency, verbal memory, motor activity and visual-motor processing/attent…

AdultMalePsychosismedicine.medical_specialtyBipolar DisorderAdolescentNeuropsychological TestsSeverity of Illness Indexmental disordersmedicineHumansVerbal fluency testAttentionBipolar disorderFirst-degree relativesPsychiatryBiological PsychiatryAgedNeuropsychologyMiddle Agedmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaFemaleVerbal memoryCognition DisordersPsychologyNeurocognitiveJournal of Psychiatric Research
researchProduct

Cataracts and statins. A disproportionality analysis using data from VigiBase.

2019

The basis of the association between statin use and cataract has been explored using the World Health Organization (WHO) global database of individual case safety reports (ICSRs) for drug monitoring (VigiBase) through January 2019. The reporting odds ratios (RORs) as a measure of disproportionality for reported cataracts and individual statins have been calculated. Subgroup analyses according statin lipophilicity, sex, and age groups have been performed. Moreover, RORs have been calculated for non-statin lipid lowering drugs. An increased disproportionality have been found for most individual statins lovastatin: [ROR: 14.80, 95% confidence interval (CI): 13.30, 16.46)], atorvastatin (ROR: 3…

AdultMalemedicine.medical_specialtyStatinAdolescentmedicine.drug_classAtorvastatin010501 environmental sciencesToxicology030226 pharmacology & pharmacy01 natural sciencesRisk AssessmentCataract03 medical and health sciencesPharmacovigilanceYoung Adult0302 clinical medicineEzetimibeInternal medicinemedicineOdds RatioAdverse Drug Reaction Reporting SystemsHumansRosuvastatinChild0105 earth and related environmental sciencesAgedAged 80 and overbusiness.industryIncidenceGeneral MedicineOdds ratioMiddle AgedSimvastatinFemaleDrug MonitoringHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessPravastatinmedicine.drugFluvastatinRegulatory toxicology and pharmacology : RTP
researchProduct

One year longitudinal study of the straight gyrus morphometry in first-episode schizophrenia-spectrum patients

2012

Brief report.-- El pdf es la versión post-print.-- et al.

AdultMalemedicine.medical_specialtyPsychosisLongitudinal studyNeuroscience (miscellaneous)Prefrontal CortexAudiologyFirst episode schizophreniaImage Processing Computer-AssistedmedicineHumansRadiology Nuclear Medicine and imagingLongitudinal Studiesskin and connective tissue diseasesPsychiatryFirst episodeNerve Fibers Unmyelinatedmedicine.diagnostic_testHealthy subjectsMagnetic resonance imagingOrgan Sizemedicine.diseasePsychiatry and Mental healthStraight gyrusPsychotic DisordersSchizophreniaStraightgyrusSchizophreniaFemalesense organsPsychologyMRIPsychiatry Research: Neuroimaging
researchProduct

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study …

2020

Publisher's version (útgefin grein)

MaleLife expectancyDisability-Adjusted Life YearDiseasesDiseasecommunicable diseasesystematic analysisGlobal Burden of Disease0302 clinical medicine80 and overMedicine10. No inequalityChild11 Medical and Health SciencesinjuriesAged 80 and overeducation.field_of_studySjúkdómarDEMENTIAFALLSGeneral MedicineForvarnir3. Good healthChild PreschoolHumanGBDPopulation health03 medical and health sciencesSDG 3 - Good Health and Well-beingHumansGlobal Burden of Disease StudyeducationAgedSpatial AnalysisGlobal burdenDisabilityPreventionDISABILITYInfantSpatial AnalysiMortality rateGlobal Burden of Disease Diseases Injuries Systematic analysisPREVENTIONYears of potential life lostRisk factorsDisease studyGBD; communicable disease; injuries;ITC-ISI-JOURNAL-ARTICLELife expectancyRISK-FACTORSClinical MedicineRADemographyFötlunDánartíðniÁhættuþættir030204 cardiovascular system & hematologyRisk FactorsCause of DeathGlobal health030212 general & internal medicineMortality ratePopulation health1. No povertyDisability-Adjusted Life YearsPublic Health Global Health Social Medicine and EpidemiologyMiddle Aged3142 Public health care science environmental and occupational healthAdolescent; Adult; Age Distribution; Aged; Aged 80 and over; Cause of Death; Child; Child Preschool; Disability-Adjusted Life Years; Female; Global Burden of Disease; Humans; Infant; Infant Newborn; Male; Middle Aged; Risk Factors; Spatial Analysis; Young Adult/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingLýðheilsaFemaleCLINICAL-TRIALSAdultAdolescentPopulationGlobal healthSettore MED/01 - Statistica MedicadiseasesITC-HYBRIDYoung AdultHeilbrigðisvísindiAge DistributionGeneral & Internal MedicineMortalityPreschoolDisease burdenbusiness.industryRisk FactorKlinisk medicinInfant NewbornNewborn//purl.org/pe-repo/ocde/ford#3.02.00 [https]Folkhälsovetenskap global hälsa socialmedicin och epidemiologiÁverkarSystematic analysisNAbusiness
researchProduct

Peripheral Oxidative Stress Markers in Patients with Bipolar Disorder during Euthymia and in Siblings.

2020

Aims:Oxidative stress is increased during the acute phases of bipolar disorder (BD). Our aim here was to analyze oxidative stress biomarkers in patients with BD during euthymia and their siblings.Method:A cross-sectional study was performed in euthymic patients with BD-I (n=48), unaffected siblings (n=23) and genetically unrelated healthy controls (n=21). Protein carbonyl content (PCC), total antioxidant capacity (TRAP), lipid peroxidation (TBARS) and uric acid were measured as biomarkers of oxidative stress in blood.Results:The antioxidant capacity (TRAP) was lower (p<0.001) in patients with BD compared to their siblings and controls, whereas no differences were observed in PCC, TBARS o…

AdultMalemedicine.medical_specialtyBipolar DisorderEndocrinology Diabetes and MetabolismProtein Carbonyl Contentmedicine.disease_causeThiobarbituric Acid Reactive SubstancesLipid peroxidationProtein Carbonylation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAntimanic AgentsInternal medicineTBARSImmunology and AllergyMedicineHumansBipolar disorderValproic Acidbusiness.industrySiblingsValproic AcidMiddle Agedmedicine.disease030227 psychiatryUric AcidOxidative StressEndocrinologyCross-Sectional StudieschemistryCase-Control StudiesBiomarker (medicine)Uric acidFemaleLipid Peroxidationbusiness030217 neurology & neurosurgeryOxidative stressBiomarkersmedicine.drugEndocrine, metabolicimmune disorders drug targets
researchProduct

Global injury morbidity and mortality from 1990 to 2017 : results from the Global Burden of Disease Study 2017

2020

Publisher's version (útgefin grein)

DánarmeinFötlunDánartíðniLífslíkurLife expectancy1106 Human Movement and Sports Sciencesburden of diseaseGlobal HealthGlobal Burden of Disease0302 clinical medicineQuality-Adjusted Life YearGlobal healthMedicineLIFE EXPECTANCY030212 general & internal medicine1506POPULATIONCause of deathOriginal ResearchRISKeducation.field_of_studyGlobal disease burdensInjuriesSjúkdómarIncidence (epidemiology)IncidencePopulation healthBurden of diseaseGlobalglobal3142 Public health care science environmental and occupational health3. Good healthDescriptive epidemiologyLýðheilsaQuality-Adjusted Life YearsPublic HealthTERRITORIESdescriptive epidemiologyHumanPopulation195 COUNTRIESPopulation healthCause of deathburden of disease; descriptive epidemiology; global; Humans; Incidence; Life Expectancy; Morbidity; Quality-Adjusted Life Years; Global Burden of Disease; Global Health; Wounds and Injuries1117 Public Health and Health Services03 medical and health sciencesAGESYSTEMATIC ANALYSISHumansMortalityeducationDisabilitySEX-SPECIFIC MORTALITYbusiness.industryFaraldsfræðiDISABILITYPublic Health Environmental and Occupational HealthQuality-adjusted life yearYears of potential life lostÁverkar1701 PsychologyLife expectancyWounds and InjuriesHuman medicineMorbiditybusiness030217 neurology & neurosurgeryDemography
researchProduct

Epigenetic outlier profiles in depression: A genome-wide DNA methylation analysis of monozygotic twins

2018

Recent discoveries highlight the importance of stochastic epigenetic changes, as indexed by epigenetic outlier DNA methylation signatures, as a valuable tool to understand aberrant cell function and subsequent human pathology. There is evidence of such changes in different complex disorders as diverse as cancer, obesity and, to a lesser extent, depression. The current study was aimed at identifying outlying DNA methylation signatures of depressive psychopathology. Here, genome-wide DNA methylation levels were measured (by means of Illumina Infinium HumanMethylation450 Beadchip) in peripheral blood of thirty-four monozygotic twins informative for depressive psychopathology (lifetime DSM-IV d…

Male0301 basic medicineTwinslcsh:MedicineBiochemistryGenomeEpigenesis GeneticDatabase and Informatics MethodsMedicine and Health SciencesDepressió psíquicalcsh:ScienceEpigenesisGeneticsDNA methylationMultidisciplinaryDepressionGenomicsMethylationMiddle AgedChromatinNucleic acidsMental depressionCpG sitePhysical SciencesDNA methylationBessonsEpigeneticsFemalegenoma humàDNA modificationChromatin modificationResearch ArticleChromosome biologyStatistical DistributionsAdultCell biologyHealth InformaticsGenomicsBiologyResearch and Analysis MethodsPolymorphism Single Nucleotidemalalties mentalsYoung Adult03 medical and health sciencesMental Health and PsychiatryGeneticsHumansEpigeneticsGeneTreatment GuidelinesHealth Care PolicyBiology and life sciencesMood Disorderslcsh:RDNATwins MonozygoticEpigenèticaProbability TheoryExpressió gènicaHealth Care030104 developmental biologylcsh:QCpG IslandsGene expressionMathematicsDevelopmental Biology
researchProduct

Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia.

2011

The World Health Organization Disability Assessment Schedule II (WHODAS II) was developed for assessing disability. This study provides data on the validity and utility of the Spanish version of the WHODAS II in a large sample of patients with schizophrenia.The sample included 352 patients with a schizophrenia spectrum disorder. They completed a comprehensive assessment battery including measures of psychopathology, functionality and quality-of-life. A sub-sample of 36 patients was retested after six months to assess its temporal stability.Participation in society (6.3%) and Life activities (4.0%) were the domains with the highest percentage of missing data. The internal consistency (Cronba…

AdultMalemedicine.medical_specialtyActivities of daily livingAdolescentPsychometricsIntraclass correlationWorld Health OrganizationSeverity of Illness IndexQuality of life (healthcare)Cronbach's alphaActivities of Daily LivingmedicineHumansDisabled PersonsPsychiatryBiological PsychiatryReproducibility of ResultsMiddle AgedMissing datamedicine.diseasePsychiatry and Mental healthPsychotic DisordersSchizophreniaScale (social sciences)Quality of LifeSchizophreniaFemalePsychologyClinical psychologyPsychopathologySchizophrenia research
researchProduct

Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015 : a systematic analysi…

2016

BACKGROUND: Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in child mortality. The Global Burden of Disease 2015 Study (GBD 2015) provides an analytical framework to comprehensively assess these trends for under-5 mortality, age-specific and cause-specific mortality among children under 5 years, and stillbirths by geography over time. METHODS: Drawing from ana…

PediatricsNutrition and DiseaseGlobal HealthCommunicable Disease0302 clinical medicineVoeding en ZiekteInfant MortalityCompensation law of mortalityGlobal healthMedicineLIFE EXPECTANCY030212 general & internal medicineDEVELOPING-COUNTRIES10. No inequalityMedicine(all)NEWBORN BABIESMedicine (all)Mortality rate1. No povertyDEATHPublic Health Global Health Social Medicine and EpidemiologyGeneral Medicine11 Medical And Health SciencesStillbirth3. Good healthChild MortalitySURVIVALCHILD-MORTALITYHEALTHLife Sciences & BiomedicineDEVELOPMENT GOAL 4HumanINTERVENTIONSmedicine.medical_specialtyRJINTEGRATED APPROACHDeveloping country610Communicable Diseasesneonatal03 medical and health sciencesMedicine General & Internal030225 pediatricsGeneral & Internal MedicineLife ScienceHumansGlobal Burden of Disease StudyVLAGEstimationScience & Technologybusiness.industryKlinisk medicinInfantGBD 2015 Child Mortality CollaboratorsInfant mortalityMalariaChild mortalityFolkhälsovetenskap global hälsa socialmedicin och epidemiologiLife expectancyClinical MedicineRGbusinessDemography
researchProduct

Additional file 1: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

PRISMA-P Checklist. (DOCX 27 kb)

3. Good health
researchProduct

Additional file 1: of Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic revi…

2019

PRISMA-P Checklist. (DOCX 33 kb)

researchProduct

Transcriptomic and Genetic Associations between Alzheimer's Disease, Parkinson's Disease, and Cancer.

2021

Simple Summary Epidemiological studies have identified a link between neurodegenerative disorders and a reduced risk of overall cancer. Increases and decreases in the risk of site-specific cancers have also been reported. However, it is still unknown whether these associations arise due to shared genetic and molecular factors or are explained by other phenomena (e.g., biases in epidemiological studies or the use of medication). In this study, we aimed to investigate the potential molecular, genetic, and pharmacological links between Alzheimer’s and Parkinson’s diseases and a large panel of 22 cancer types. To examine the overlapping involvement of genes and pathways, we obtained differentia…

0301 basic medicineOncologyCancer ResearchParkinson's diseaseGenetic correlationsGenome-wide association studyDiseaseComorbidityParkinson Enfermedad de - Aspectos genéticos.chemistry.chemical_compound0302 clinical medicineExemestaneParkinson's disease - Genetic aspects.MedicineParkinsonCáncer - Aspectos genéticos.Càncer -- Aspectes genèticsRC254-282Alzheimer's disease - Genetic aspects.NeurodegenerationNeoplasms. Tumors. Oncology. Including cancer and carcinogensCódigo genético.comorbidityOncology:Informàtica::Aplicacions de la informàtica::Bioinformàtica [Àrees temàtiques de la UPC]medicine.medical_specialtyGenetic code.Alzheimer Enfermedad de - Aspectos genéticos.Article03 medical and health sciencesInternal medicineParkinson Malaltia dePI3K/AKT/mTOR pathwaygenetic correlationsCancer - Genetic aspects.business.industryCancertranscriptomicmedicine.diseaseComorbidityAlzheimer Malaltia d'030104 developmental biologychemistryTranscriptomicmeta-analysesMeta-analysesNeurodegenerative disordersAlzheimerGene expressionbusiness030217 neurology & neurosurgeryCancers
researchProduct

Predictors of clinical remission following a first episode of non-affective psychosis: Sociodemographics, premorbid and clinical variables

2012

The aim of the study was to identify predictors associated with a lower likelihood of achieving a clinical remission 1 year after the first break of the illness. Participants were 174 consecutive subjects included in a first episode programme with no prior treatment with antipsychotic medication. Patients were assigned to haloperidol, olanzapine or risperidone in a randomized, open-label, prospective clinical trial. The main outcome variable was the remission criteria developed by the Remission in Schizophrenia Working Group. Clinical variables were included in a logistic regression analysis in order to predict the remission state at 1 year. At 1 year, 31% of patients met criteria for remis…

AdultMaleOlanzapinePediatricsmedicine.medical_specialtymedicine.medical_treatmentLogistic regressionSeverity of Illness IndexTime-to-TreatmentBenzodiazepinesYoung AdultRisk FactorsmedicineHumansLongitudinal StudiesAntipsychoticPsychiatryBiological PsychiatryFirst episodeRisperidoneRemission InductionPrognosisRisperidonemedicine.diseaseClinical trialPsychiatry and Mental healthLogistic ModelsPsychotic DisordersOlanzapineSchizophreniadupSchizophreniaEducational StatusHaloperidolFemaleSchizophrenic PsychologyPsychologyAntipsychotic Agentsmedicine.drugPsychiatry Research
researchProduct

Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in s…

2007

The Screen for Cognitive Impairment in Psychiatry (SCIP) is a brief scale designed for detecting cognitive deficits in several psychotic and affective disorders. This study examined the psychometric properties of the Spanish version of the SCIP in a sample of outpatients suffering schizophrenia-spectrum disorders.Psychometric properties were evaluated in a sample of 126 stable patients with schizophrenia. Men and women 18 to 55 years of age were recruited from consecutive admissions to 40 psychiatric outpatient clinics in Spain and asked to complete a series of cognitive measures at baseline, as well as three versions of the SCIP separated by one week intervals. A matched sample of 39 healt…

AdultCross-Cultural ComparisonMalemedicine.medical_specialtyPsychometricsAdolescentPsychometricsConcurrent validityTest validityNeuropsychological TestsCronbach's alphaReference ValuesmedicineOutpatient clinicHumansMass ScreeningPsychiatryBiological PsychiatryMass screeningLanguageCognitive disorderNeuropsychologyReproducibility of ResultsMiddle Agedmedicine.diseasePsychiatry and Mental healthPsychotic DisordersSpainSchizophreniaFemaleSchizophrenic PsychologyPsychologyCognition DisordersClinical psychologySchizophrenia research
researchProduct

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systema…

2015

[Background] Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of children and adolescents, with a significant impact on health services and the community in terms of economic and social burdens. The objective of this systematic review will be to evaluate the comparative efficacy and safety of pharmacological and non-pharmacological treatments in children and adolescents with ADHD.

Complementary Therapiesmedicine.medical_specialtyAdolescentPsychological interventionMEDLINEMedicine (miscellaneous)law.inventionAttention deficit hyperactivity disorder03 medical and health sciences0302 clinical medicineClinical ProtocolsRandomized controlled trialCognició en els infantsBehavior Therapylawmental disordersOutcome Assessment Health CareProtocolHumansADHDMedicineAttention deficit hyperactivity disorder030212 general & internal medicineChildPsychiatryChildrenInfants hiperactiusbusiness.industrymedicine.diseaseChiropractic3. Good healthTreatmentClinical trialMeta-analysisSystematic reviewAttention Deficit Disorder with HyperactivityResearch DesignMeta-analysisSystematic reviewbusiness030217 neurology & neurosurgeryCentral Nervous System AgentsSystematic Reviews as TopicSystematic Reviews
researchProduct

Lifestyle in Undergraduate Students and Demographically Matched Controls during the COVID-19 Pandemic in Spain

2021

Few studies have used a multidimensional approach to describe lifestyle changes among undergraduate students during the COVID-19 pandemic or have included controls. This study aimed to evaluate lifestyle behaviors and mental health of undergraduate students and compare them with an age and sex-matched control group. A cross-sectional web survey using snowball sampling was conducted several months after the beginning of COVID-19 pandemic in Spain. A sample of 221 students was recruited. The main outcome was the total SMILE-C score. Students showed a better SMILE-C score than controls (79.8 + 8.1 vs. 77.2 + 8.3

Stress managementlifestyleCross-sectional studyHealth Toxicology and MutagenesiseducationAlcohol abuseEstudiants universitarisAnxietyArticleEstilo de vida03 medical and health sciencesYoung Adult0302 clinical medicineMedicineHumans030212 general & internal medicineYoung adultEspanyaCollege studentsStudentsLife StylePandemicsPandemiasbusiness.industryDepressionSARS-CoV-2pandemicPublic Health Environmental and Occupational HealthRCOVID-19EspanhaMental illnessmedicine.diseaseMental healthSaúde mentalundergraduate studentsSubstance abuseCross-Sectional StudiesSpainAnxietyMedicinemedicine.symptombusinessEstudantes030217 neurology & neurosurgerymental healthDemographyInternational Journal of Environmental Research and Public Health
researchProduct

Additional file 2: of Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity diso…

2017

Key terms for PubMed/MEDLINE search. (DOCX 20 kb)

3. Good health
researchProduct

Comparing neurocognitive impairment in schizophrenia and bipolar I disorder using the Screen for Cognitive Impairment in Psychiatry Scale

2014

AbstractThe purpose of this study was to compare the psychometric properties of the Screen for Cognitive Impairment in Psychiatry (SCIP) when applied to patients diagnosed with schizophrenia (n=126) or bipolar I disorder (n=76), and also to compare the cognitive impairment in both samples of patients and a control group (n=83) using the SCIP and a complete neuropsychological battery. The SCIP is a scale intended to quickly and easily assess cognitive impairment in patients with severe psychiatric disorders. The results showed firstly that, in terms of internal consistency, temporal stability, dimensional structure, and criterion-referenced validity, the SCIP provides reliable and valid scor…

medicine.medical_specialtyBipolar I disorderCognition disordersBipolar disorderlcsh:BF1-990EsquizofreniaDeterioro cognitivoTrastorns de la cognicióInstrumental studymedicineManic-depressive illnessIn patientBipolar disorderCognitive impairmentPsychiatryTrastorn bipolarTrastorno bipolarEstudio instrumentalNeuropsychological batterymedicine.diseaseScreen for Cognitive Impairment in PsychiatryClinical PsychologyCognitive impairmentlcsh:PsychologySchizophreniaSchizophreniaEsquizofrèniaVerbal memoryPsychologyNeurocognitiveInternational Journal of Clinical and Health Psychology
researchProduct

Duration of active psychosis and functional outcomes in first-episode non-affective psychosis.

2018

AbstractBackground:The duration of untreated psychosis (DUP) has been associated with negative outcomes in psychosis; however, few studies have focused on the duration of active psychotic symptoms after commencing treatment (DAT). In this study, we aimed to evaluate the effect of DUP and DAT on functional long-term outcomes (3 years) in patients with early psychosis.Methods:We evaluated the Scale for the Assessment of Positive Symptoms (SAPS) at frequent intervals for 3 years after presentation to determine the DAT for 307 individuals with first-episode psychosis together with DUP and clinical variables. The functional outcomes were assessed using the Disability Assessment Scale (DAS) at th…

AdultMalePsychosismedicine.medical_specialtyTime FactorsLogistic regressionCohort Studies03 medical and health sciencesDisability Evaluation0302 clinical medicineActivities of Daily LivingmedicineHumansProspective StudiesPsychiatryProspective cohort studyFirst episodePsychiatric Status Rating ScalesReceiver operating characteristicbusiness.industrymedicine.disease030227 psychiatryPsychiatry and Mental healthTreatment OutcomePsychotic DisordersSchizophreniaNon affective psychosisdupSchizophreniaFemaleSchizophrenic PsychologybusinessSocial Adjustment030217 neurology & neurosurgeryAntipsychotic AgentsEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

Neurocognitive Impairment Across the Bipolar Spectrum

2011

Bipolar disorder is a severe mental illness that affects nearly 4.4% of the general population when bipolar spectrum disorders are taken into account. Neurocognitive impairment is thought to be a core deficit of this illness since it is present during euthymia. In fact, 40–60% of euthymic patients present with neurocognitive disturbances. Not only the clinical factors but also disturbances in neurocognition can influence the functional outcome of BD patients. Hence, further research is needed in order to clarify the relationship between these variables. Despite the growing body of evidence that has emerged during the last decade, no unique neurocognitive profile has been proposed yet for ei…

Pharmacologymedicine.medical_specialtyeducation.field_of_studyBipolar Disordermedicine.diagnostic_testPopulationNeuropsychological Testsmedicine.diseaseMental illnessPsychiatry and Mental healthPhysiology (medical)medicineHumansPharmacology (medical)Bipolar disorderNeuropsychological assessmentCognition DisordersPsychologyPsychiatryeducationReviews (Special Issue for Bipolar Disorder)NeurocognitiveClinical psychologyCNS Neuroscience & Therapeutics
researchProduct

Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017

2020

Artículo con numerosos autores, sólo se mencionan el primero, los de la UAM y grupo colectivo

MaleLocal patternsDouble burdenBörnResearch & Experimental MedicineSjúkdómseinkenniDOUBLE BURDENChildhood overweightLífefnafræðiLæknisfræði0302 clinical medicineSyndemicChild11 Medical and Health Sciencesunder 5 years of ageGeneral Medicine3. Good healthGeographyMedicine Research & ExperimentalChild PreschoolIncomeGROWTHAFRICAmedicine.medical_specialtyBiochemistry & Molecular BiologyRJMedicinaImmunologyeducationMODELSwa_395General Biochemistry Genetics and Molecular BiologyArticleG03 medical and health sciencesHumansAuthor CorrectionDeveloping CountriesPovertyBiologyLBD Double Burden of Malnutrition CollaboratorsDemographyScience & TechnologyWasting SyndromePublic healthMORTALITYInfantNæringarskorturmedicine.diseaseObesityTRENDSsigns and symptomsSocial ClassRisk factorsSameindalíffræðiITC-ISI-JOURNAL-ARTICLEUNDERNUTRITIONHuman medicineClinical Medicine030217 neurology & neurosurgeryPediatric ObesityobesityOffitaÁhættuþættirGeographic MappingOverweightRA0421Global healthrisk factors030212 general & internal medicineSigns and symptomsWastingMalnutrition Global Burden of Diseases Global Nutrition low- and middle-income countries2. Zero hungerPublic health1. No povertyPublic Health Global Health Social Medicine and EpidemiologyA900 Others in Medicine and DentistryChildhood wastingPREVALENCEChemistryMappingFemaleLýðheilsamedicine.symptomLife Sciences & BiomedicineGROWTH FAILURENutritional StatusmalnutritionITC-HYBRIDws_115childrenEnvironmental healthmedicineErfðafræðiObesitywd_200MalnutritionInfant NewbornKlinisk medicinCell BiologyOverweightMalnutritionFolkhälsovetenskap global hälsa socialmedicin och epidemiologi3121 General medicine internal medicine and other clinical medicineNA
researchProduct

Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

2020

Background Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attributable burden of disease. Methods GBD 2019 estimated attributable mortality, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 87 risk factors and combinations of risk factors, at the…

MaleNutritional SciencesSpecific riskContaminación del Aire Interior030204 cardiovascular system & hematologySocioeconomic Factorsystematic analysisGlobal HealthBody Mass IndexGlobal Burden of DiseaseHealth Risk BehaviorHealth Risk BehaviorsDisease studies0302 clinical medicineRisk FactorsMETABOLIC RISKS030212 general & internal medicine11 Medical and Health SciencesFactores de Riesgo2. Zero hungereducation.field_of_studyPublic healthInjuriesPublic Health Global Health Social Medicine and EpidemiologyGeneral MedicineGBD; risck factors; attributable burden of disease;3142 Public health care science environmental and occupational health3. Good healthRelative riskEnvironmental healthHealthHypertension/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingGlobal Burden of Diseases Injuries Risk FactorsA990 Medicine and Dentistry not elsewhere classifiedFemaleLeading risk factorsGlobal Health MetricsCohort studyHumanmedicine.medical_specialtySubstance-Related DisordersPopulationUNITED-STATESRisk AssessmentDIETITC-HYBRID03 medical and health sciencesLife ExpectancyUNITED-STATES; MORTALITY; DISABILITY; POLLUTION; CLUSTERS; DIETSDG 3 - Good Health and Well-beingPOLLUTIONGeneral & Internal MedicineEnvironmental healthmedicineHumansGlobal Burden of Disease StudyRisk factoreducationGlobal burdenbusiness.industryPublic healthRisk FactorMORTALITYDISABILITYMalnutritionKlinisk medicinGlobal Burden of DiseasesEnvironmental Exposuremedicine.diseaseEnfermedades//purl.org/pe-repo/ocde/ford#3.02.00 [https]MalnutritionFolkhälsovetenskap global hälsa socialmedicin och epidemiologiYears of potential life lostSocioeconomic FactorsRisk factorsDisease studyRelative riskHyperglycemiaITC-ISI-JOURNAL-ARTICLENAClinical MedicinebusinessCLUSTERSRA
researchProduct

Sex-specific variation of MRI-based cortical morphometry in adult healthy volunteers: The effect on cognitive functioning

2011

Previous investigations have revealed sex-specific differences in brain morphometry. The effect of sex on cortical thickness may be influencing cognitive differences between sexes. With this exploratory study, we aimed to investigate the effect of sex in MRI-based cerebral cortex morphometry in healthy young volunteers and how the variability in cortical measures might affect cognitive functioning in men and women. 76 young healthy volunteers (45 men and 31 women) underwent a 1.5 T MR scan and 53 of them completed a comprehensive cognitive battery. Overall no gross significant differences between sexes were found in cortical thickness, surface area and curvature indexes. However, there was …

AdultMalemedicine.medical_specialtyAdolescentmedia_common.quotation_subjectAptitudeAudiologyAffect (psychology)ArticleDevelopmental psychologyYoung AdultCognitionmedicineHumansYoung adultBiological Psychiatrymedia_commonCerebral CortexPharmacologySex CharacteristicsBrain morphometryCognitionMiddle AgedMagnetic Resonance ImagingSexual dimorphismmedicine.anatomical_structureCerebral cortexFemaleAptitudePsychologySex characteristicsProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

The global burden of cancer attributable to risk factors, 2010–19 : A systematic analysis for the Global Burden of Disease Study 2019

2022

Background: Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods: The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 20…

MaleDEATHSDALY cancer risk factorsMedizinsystematic analysisGlobal HealthRisk AssessmentCancer preventionGlobal Burden of DiseaseRC0254Risk-attributable cancer deathsSDG 3 - Good Health and Well-beingRA0421Risk FactorsRA0421 Public health. Hygiene. Preventive MedicineQuality-Adjusted Life YearNeoplasmscancerHumansGlobal Burden of Disease StudyUKMedicine(all)MCCRC0254 Neoplasms. Tumors. Oncology (including Cancer)Risk FactorSmokingCOVID-193rd-DASGeneral MedicineDisability-adjusted life-yearsSOCIAL DETERMINANTSRisk assessmentsrisk factorCardiovascular and Metabolic Diseases3121 General medicine internal medicine and other clinical medicineOBESITYCancer burden/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingNeoplasmFemaleLIFE-STYLEQuality-Adjusted Life YearsHEALTHRAHumanRC
researchProduct

Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses.

2014

There is epidemiological evidence that patients with certain Central Nervous System (CNS) disorders have a lower than expected probability of developing some types of Cancer. We tested here the hypothesis that this inverse comorbidity is driven by molecular processes common to CNS disorders and Cancers, and that are deregulated in opposite directions. We conducted transcriptomic meta-analyses of three CNS disorders (Alzheimer's disease, Parkinson's disease and Schizophrenia) and three Cancer types (Lung, Prostate, Colorectal) previously described with inverse comorbidities. A significant overlap was observed between the genes upregulated in CNS disorders and downregulated in Cancers, as wel…

Central Nervous SystemCancer ResearchGene ExpressionDiseaseComorbidityBioinformaticsProstate cancer0302 clinical medicineNeoplasmsGenetics (clinical)0303 health sciencesWnt signaling pathwayParkinson DiseaseAlzheimer's diseasePeptidylprolyl Isomerase[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]3. Good health[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Alzheimer's diseaseResearch ArticleSignal Transductionlcsh:QH426-470[SDV.CAN]Life Sciences [q-bio]/CancerProtein degradationBiology03 medical and health sciencesAlzheimer Disease[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]medicineGeneticsCancer GeneticsHumansGene NetworksMolecular BiologyBiologyEcology Evolution Behavior and Systematics030304 developmental biologyPeptidylprolyl isomeraseGene Expression ProfilingCancerComputational Biologymedicine.diseaseColorectal cancerComorbidityMalariaNIMA-Interacting Peptidylprolyl IsomeraseMeta-analysislcsh:GeneticsGene Expression RegulationImmunologySchizophrenia[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie030217 neurology & neurosurgery
researchProduct

Additional file 1: of The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review

2016

Reporting methods and results of CEA Spain_annex. Table S1. PubMed/MEDLINE search strategy. Table S2. Included studies. Table S3. PRISMA Checklist. Figure S1. Flow diagram for study selection. Figure S2. Growth in published cost-effectiveness analyses. Spain, 1989-2014.

researchProduct

Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5…

2017

Background: Few studies have examined Manual Motor Speed (MMS) in bipolar disorder (BD). The aim of this longitudinal, family study was to explore whether dysfunctional MMS represents a neurocognitive endophenotype of BD. Methods: A sample of 291 subjects, including 131 BD patients, 77 healthy first-degree relatives (BD-Rel), and 83 genetically-unrelated healthy controls (HC), was assessed with the Finger-Tapping Test (En) on three occasions over a 5-year period. Dependence of FTT on participants' age was removed by means of a lineal model of HC samples, while correcting simultaneously the time and learning effect. Differences between groups were evaluated with an ANOVA test. Results: The p…

AdultMalemedicine.medical_specialtyLongitudinal studyBipolar DisorderAdolescentEndophenotypesBipolar disorderDysfunctional familyAffect (psychology)Young AdultManual motor speed03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansFamilyMotor speedLongitudinal StudiesBipolar disorderPsychiatryNeurocognitionAgedAnalysis of VarianceCarbamazepineMiddle Agedmedicine.diseaseFamily study030227 psychiatryMotor Skills DisordersEndophenotypePsychiatry and Mental healthClinical PsychologyMotor SkillsCase-Control StudiesEndophenotypeFemaleLongitudinal studyPsychologyNeurocognitivePsychomotor Performance030217 neurology & neurosurgerymedicine.drug
researchProduct

The global distribution of lymphatic filariasis, 2000–18:a geospatial analysis

2020

Background Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to eliminate lymphatic filariasis as a public health problem. This study aims to produce the first geospatial estimates of the global prevalence of lymphatic filariasis infection over time, to quantify progress towards elimination, and to identify geographical variation in distribution of infection. Methods A global dataset of georeferenced surveyed locations was used to model annual 2000–18 lym…

medicine.medical_specialtyGeospatial analysis030231 tropical medicineElephantiasis:ELIMINATIONcomputer.software_genreArticleLocal Burden of Disease 2019 Neglected Tropical Diseases Collaborators1117 Public Health and Health Services03 medical and health sciences0302 clinical medicineRA0421Environmental healthGlobal healthmedicine030212 general & internal medicineMass drug administrationLymphatic filariasisPublic healthlcsh:Public aspects of medicineTropical diseaselcsh:RA1-1270General Medicinemedicine.disease3. Good healthQRGeographyLymphatic systemITC-ISI-JOURNAL-ARTICLEA990 Medicine and Dentistry not elsewhere classifiedITC-GOLDcomputer0605 Microbiology
researchProduct

MOESM6 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 6. Exploratory analysis of topical data.

Data_FILES3. Good health
researchProduct

Global Mortality From Firearms, 1990-2016

2018

IMPORTANCE: Understanding global variation in firearm mortality rates could guide prevention policies and interventions. OBJECTIVE: To estimate mortality due to firearm injury deaths from 1990 to 2016 in 195 countries and territories. DESIGN, SETTING, AND PARTICIPANTS: This study used deidentified aggregated data including 13 812 location-years of vital registration data to generate estimates of levels and rates of death by age-sex-year-location. The proportion of suicides in which a firearm was the lethal means was combined with an estimate of per capita gun ownership in a revised proxy measure used to evaluate the relationship between availability or access to firearms and firearm injury …

MaleGlobal Health01 natural sciences0302 clinical medicineFirearm injuryArmas de FuegoHomicideGlobal healthMedicine030212 general & internal medicineYoung adultChildAged 80 and overMortality rateArmes de foc11 Medical And Health SciencesGeneral MedicineMiddle Aged16. Peace & justiceFirearm suicideSuicideGun ownershipChild PreschoolViolenciaFemaleHomicideAdultFirearmsAdolescentUncertainty intervalViolenceYoung Adult03 medical and health sciencesAge DistributionGeneral & Internal MedicineMortalitatHumansVital registrationSuicidioSex Distribution0101 mathematicsMortalityAgedbusiness.industry010102 general mathematicsInfant NewbornInfantHeridas por Arma de FuegoHomicidioMortalidadWounds GunshotHuman medicinebusinessDemographyJAMA - Journal of the American Medical Association
researchProduct

Childhood trauma and substance use underlying psychosis: a systematic review

2020

[EN] Background: Schizophrenia spectrum disorders (SSD) are mental diseases caused by a combination of genetic susceptibility and a number of environmental factors. Among these factors, the role of traumatic events suffered in childhood, as well as that of substance use, have been of particular research interest. Objectives: To conduct a systematic review to clarify whether there is an interaction between childhood trauma and substance use related to the diagnosis or symptoms of SSD. It was also the objective of this review to collate the associations that may exist between the three variables of the study (trauma, substance use and psychosis). Methods: We conducted a systematic search resu…

PsychosisSubstances useRC435-571Poison controlEsquizofreniaReview Article药物滥用Cannabis useSuicide preventionOccupational safety and healthChildhood traumaConsumo de cannabis思觉失调Injury preventionmedicinePsicosisPsychiatryWindow of opportunitybusiness.industryHuman factors and ergonomicsConsumo de sustanciasmedicine.diseasePsychosis• Schizophrenia is caused by a combination of genetic susceptibility and a number of environmental factors. Traumatic events suffered in childhood as well as substance use have been of particular interest.• Our results reveal a positive association between traumatic experiences in childhood and drug use and their interaction with schizophrenia spectrum disorders.• Detecting cases of childhood trauma as well as cases of trauma associated with substance use could be useful for the primary prevention of some psychiatric diseases such as psychosis.大麻使用精神分裂症SchizophreniaTrauma infantilSchizophreniabusiness童年创伤Clinical psychology
researchProduct

Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases S…

2022

Background: Disability and mortality burden of non-communicable diseases (NCDs) have risen worldwide; however, the NCD burden among adolescents remains poorly described in the EU. Methods: Estimates were retrieved from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Causes of NCDs were analysed at three different levels of the GBD 2019 hierarchy, for which mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) were extracted. Estimates, with the 95% uncertainty intervals (UI), were retrieved for EU Member States from 1990 to 2019, three age subgroups (10–14 years, 15–19 years, and 20–…

Malemortality burdenAdolescentRJRJ101CareGlobal Burden of DiseaseLife ExpectancyRJ101 Child Health. Child health servicesSDG 3 - Good Health and Well-beingRA04213123 Gynaecology and paediatricsRisk FactorsRA0421 Public health. Hygiene. Preventive MedicineDevelopmental and Educational PsychologyHumansDisabled PersonsNoncommunicable DiseasesFutureDeterminantsMCCDisabilityPublic Health Global Health Social Medicine and EpidemiologyBurden of non-communicable diseases among adolescents aged 10–24 years in the EU 1990–2019: a systematic analysis of the Global Burden of Diseases Study 20193rd-DASDisability; mortality burdenFolkhälsovetenskap global hälsa socialmedicin och epidemiologin/aHealthPediatrics Perinatology and Child HealthFemaleRA
researchProduct

Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis

2020

INTRODUCTION: There has been a growing awareness of the need for rigorously and transparent reported health research, to ensure the reproducibility of studies by future researchers. Health economic evaluations, the comparative analysis of alternative interventions in terms of their costs and consequences, have been promoted as an important tool to inform decision-making. The objective of this study will be to investigate the extent to which articles of economic evaluations of healthcare interventions indexed in MEDLINE incorporate research practices that promote transparency, openness and reproducibility. METHODS AND ANALYSIS: This is the study protocol for a cross-sectional comparative ana…

Cost-Benefit Analysisdata sharingMEDLINEcost-effectiveness analysis data sharing methodology quality reporting reproducibility03 medical and health sciencesHealth Economics0302 clinical medicineHealth careProtocolOpenness to experienceHumansMedicine17011506030212 general & internal medicinereproducibilityProtocol (science)reportingMedical educationbusiness.industry030503 health policy & servicesCost-effectiveness analysiscost-effectiveness analysisRMethodologyReproducibility of ResultsmethodologyGeneral MedicineCost-effectiveness analysisTransparency (behavior)QualityReproducibility3. Good healthEconomics MedicalData sharingCross-Sectional StudiesReportingResearch DesignqualityEconomic evaluationMedicineData sharingQuality-Adjusted Life Years0305 other medical sciencebusiness
researchProduct

Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

2023

Background The COVID-19 pandemic highlighted gaps in health surveillance systems, disease prevention, and treatment globally. Among the many factors that might have led to these gaps is the issue of the financing of national health systems, especially in low-income and middle-income countries (LMICs), as well as a robust global system for pandemic preparedness. We aimed to provide a comparative assessment of global health spending at the onset of the pandemic; characterise the amount of development assistance for pandemic preparedness and response disbursed in the first 2 years of the COVID-19 pandemic; and examine expectations for future health spending and put into context the expected ne…

coordinationcommunicationoutbreak responseCOVID-19 GBDresponse planPublic Health Global Health Social Medicine and EpidemiologyGeneral Medicinecontact managementpandemic Covid 19financingepidemic alertepidemiological investigationFolkhälsovetenskap global hälsa socialmedicin och epidemiologiinternational health regulationsurveillanceGlobal burden diseasefinancing; global spending; pandemic Covid 19;global spendingpreparedne
researchProduct

MOESM5 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 5. List of excluded articles.

Data_FILESTheoryofComputation_GENERALGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)3. Good health
researchProduct

MOESM2 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 2. Data extraction and normalisation processes.

TheoryofComputation_MATHEMATICALLOGICANDFORMALLANGUAGESComputingMethodologies_SYMBOLICANDALGEBRAICMANIPULATIONData_FILES3. Good health
researchProduct

Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

BACKGROUND: Anorexia nervosa is characterized by a severe restriction of caloric intake, low body weight, fear of gaining weight or of becoming fat, and disturbance of body image. Pathogenesis of the disorder may include genetic predisposition, hormonal changes and a combination of environmental, psychosocial, and cultural factors. Cancer is the second leading cause of death worldwide. At present, no systematic reviews and meta-analyses have evaluated the risk of cancer in people with anorexia nervosa. The objective of this study will be to evaluate the association between anorexia nervosa and the risk of developing or dying from cancer. METHODS/DESIGN: This study protocol is part of a syst…

medicine.medical_specialtyAnorexia NervosaEpidemiological studyMedicine (miscellaneous)lcsh:Medicine03 medical and health sciences0302 clinical medicineNeoplasmsEpidemiologymental disordersmedicineProtocolHumans030212 general & internal medicinePsychiatryCancerbusiness.industryIncidencelcsh:REating disorderCancerCáncermedicine.disease3. Good healthMeta-analysisSystematic reviewAnorexia nervosa (differential diagnoses)030220 oncology & carcinogenesisMeta-analysisCohortSystematic reviewbibliometríaObservational studybusinessPsychosocialanorexia nerviosaSystematic Reviews as Topic
researchProduct

GLOBAL AND REGIONAL CORTICAL THINNING IN FIRST-EPISODE SCHIZOPHRENIA PATIENTS: RELATIONSHIPS WITH CLINICAL AND COGNITIVE FEATURES

2010

Psychiatry and Mental healthmedicine.medical_specialtyPhysical medicine and rehabilitationbusiness.industrymedicineCortical thinningCognitionFirst episode schizophreniabusinessBiological PsychiatrySchizophrenia Research
researchProduct

Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients

2010

International audience; n.a

medicine.medical_specialtyPsychotherapistlcsh:RC435-571[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health3. Good health030227 psychiatry03 medical and health sciencesPsychiatry and Mental health0302 clinical medicinelcsh:PsychiatryForensic psychiatry[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthMeeting AbstractmedicinePsychopharmacologyPsychiatryPsychologyNeurocognitive030217 neurology & neurosurgeryGeriatric psychiatryComputingMilieux_MISCELLANEOUS
researchProduct

MOESM1 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 1. Full strategy in PubMed/MEDLINE.

3. Good health
researchProduct

Clinical staging and serum cytokines in bipolar patients during euthymia

2017

Aims: Changes in serum cytokines and altered neutrophin concentration have been associated with bipolar disorder (BD). Our aim here was to analyze peripheral blood biomarkers according to the clinical stages of BD. Method: Euthymic BD-I patients were grouped according to their level of functioning in early-stage (n = 25) and late-stage (n = 23), and compared to healthy siblings (n = 23) and genetically unrelated healthy controls (n = 21). Neurotrophin (neurotrophin-3 and BDNF) concentration and biomarkers of inflammation, including cytokines (IL-6, IL-10 and TNF-alpha), leukocytes count and acute phase proteins, were measured. Results: IL-10 concentration was significantly increased in earl…

AdultMaleBipolar DisorderBipolar disorderInflammationNeurotrophinsYoung Adult03 medical and health sciences0302 clinical medicineNeurotrophin 3medicineLeukocytesHumansNerve Growth FactorsBipolar disorderBiological PsychiatryPharmacologyInflammationbiologyInterleukin-6Tumor Necrosis Factor-alphabusiness.industryBrain-Derived Neurotrophic FactorSiblingsAcute-phase proteinMiddle Agedmedicine.diseaseBlood Cell CountInterleukin-10030227 psychiatryPeripheralAffectSerum cytokineClinical stagingCase-Control StudiesImmunologybiology.proteinBiomarker (medicine)CytokinesFemaleTumor necrosis factor alphamedicine.symptombusinessBiomarkers030217 neurology & neurosurgeryAcute-Phase ProteinsNeurotrophin
researchProduct

Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

2019

Since 2000, many countries have achieved considerable success in improving child survival, but localized progress remains unclear. To inform efforts towards United Nations Sustainable Development Goal 3.2—to end preventable child deaths by 2030—we need consistently estimated data at the subnational level regarding child mortality rates and trends. Here we quantified, for the period 2000–2017, the subnational variation in mortality rates and number of deaths of neonates, infants and children under 5 years of age within 99 low- and middle-income countries using a geostatistical survival model. We estimated that 32% of children under 5 in these countries lived in districts that had attained ra…

SurvivalRJ101Mortalidad InfantilHBUNDER-5 MORTALITYGlobal HealthPediatrics0302 clinical medicine3123 Gynaecology and paediatricsChild deathInfant MortalityEpidemiologyGlobal healthMiddle income countryNacimiento vivo030212 general & internal medicine10. No inequalityChildPOPULATIONDeveloping worldeducation.field_of_studyPublic healthMultidisciplinaryGeographyMortality ratewa_9001. No povertyRSUCCESSPediatrikA900 Others in Medicine and Dentistry3142 Public health care science environmental and occupational health3. Good healthChild MortalityDeath childrenVACCINATIONHEALTHws_100INTERVENTIONSAFRICAmedicine.medical_specialtyUnited NationsGeneral Science & Technology030231 tropical medicinePopulationDeveloping countryArticleHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]ITC-HYBRID03 medical and health sciencesAll institutes and research themes of the Radboud University Medical CenterSocial JusticeRecién nacidoNeonatal deathsmedicineSYSTEMATIC ANALYSISOrganizational ObjectivesHumanseducationDeveloping Countriesbusiness.industryPublic healthInfant NewbornInfantCIVIL REGISTRATIONPaediatricsChild survivalNewbornPREVENTIONMortality rateInfant mortalitywa_320ws_200Child mortalitySocioeconomic FactorsITC-ISI-JOURNAL-ARTICLEHuman medicinePaediatrics Public health Developing worldbusinessDemography
researchProduct

Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease St…

2022

Correction to Lancet Gastroenterol Hepatol 2022; 7: 627-47. Lancet Gastroenterol Hepatol. 2022 Aug;7(8):704. doi: 10.1016/S2468-1253(22)00210-2. PMID: 35809605. Background: Colorectal cancer is the third leading cause of cancer deaths worldwide. Given the recent increasing trends in colorectal cancer incidence globally, up-to-date information on the colorectal cancer burden could guide screening, early detection, and treatment strategies, and help effectively allocate resources. We examined the temporal patterns of the global, regional, and national burden of colorectal cancer and its risk factors in 204 countries and territories across the past three decades. Methods: Estimates of incidenc…

AdultMED/42 - IGIENE GENERALE E APPLICATAIMPACTcolorectal cancerColorectal NeoplasmGBD 2019 Colorectal Cancer CollaboratorsHEREDITARYGlobal Burden of DiseaseCancer screeningDISPARITIESSDG 3 - Good Health and Well-beingCancer treatment strategiesRisk FactorsQuality-Adjusted Life YearCOLONGlobal studiesDALY GBD colorectal cancerrisk factorsHumansGlobal Burden of Disease StudyEarly Detection of CancerHepatologyMORTALITYGastroenterologyCancer incidence ratesMiddle AgedCancer burdenSURVIVAL/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSEXGENDERQuality-Adjusted Life YearsColorectal NeoplasmsHumanThe Lancet Gastroenterology & Hepatology
researchProduct

Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

2016

BACKGROUND: In transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame policy discussions. We aimed to quantify maternal mortality throughout the world by underlying cause and age from 1990 to 2015.METHODS: We estimated maternal mortality at the global, regional, and national levels from 1990 to 2015 for ages 10-54 years by systematically compiling and processing all available data sources from 186 of 195 countries and territories, 11 of which were analysed at the subnational level. We quantified eight underl…

0301 basic medicinePediatricsNutrition and DiseaseMILLENNIUM DEVELOPMENT GOALSSUSTAINABLE DEVELOPMENT GOALSANTENATAL CAREGlobal Health0302 clinical medicineVoeding en Ziekte11. SustainabilityGlobal healthHQHealthcare FinancingEMERGENCY OBSTETRIC CARE030212 general & internal medicineCooperative Behavior10. No inequalityReproductive healthMedicine(all)education.field_of_study030219 obstetrics & reproductive medicineMedicine (all)1. No povertyObstetrics and GynecologyPublic Health Global Health Social Medicine and EpidemiologyPrenatal CareGeneral Medicine11 Medical And Health SciencesLOW-RESOURCE SETTINGS3142 Public health care science environmental and occupational healthFamily Planning Service3. Good healthGBD 2015 Maternal Mortality CollaboratorsGovernment ProgramsMaternal MortalityReproductive HealthFamily Planning ServicesMaternal deathHEALTHLife Sciences & BiomedicineHumanCOUNTRIESmedicine.medical_specialtyPopulation610Prenatal careArticle03 medical and health sciencesMedicine General & InternalSDG 3 - Good Health and Well-beingCASH TRANSFER PROGRAMEnvironmental healthGeneral & Internal Medicineparasitic diseasesmedicineLife ScienceQUALITYHumansGlobal Burden of Disease StudyeducationVLAGScience & TechnologyMedical Assistancebusiness.industryKlinisk medicinParturitionObstetric transitionmedicine.diseaseQPInfant mortalityFolkhälsovetenskap global hälsa socialmedicin och epidemiologiStandardized mortality ratio030104 developmental biologyRISK-FACTORSRGClinical MedicinebusinessRA
researchProduct

Course of cognitive deficits in first episode of non-affective psychosis: a 3-year follow-up study.

2013

Abstract Cognitive dysfunctions are critical determinants of the quality of life and functionality in schizophrenia. Whether the cognitive deficits present at an early stage, are static or change across one's lifespan is still under debate. This study aims to investigate the long-term (3 years) course of cognitive deficits in a large and representative cohort of first episode schizophrenia spectrum patients (N = 155),and evaluate their influence on disability. In addition, a healthy control sample (N = 43) was also studied for comparison. This study evaluates the performance of patients and controls in a battery of cognitive assessments using baseline, 1-year and 3-year follow-up designs. T…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentNeuropsychological TestsCohort StudiesYoung AdultVisual memorymedicineHumansSpectrum disorderEffects of sleep deprivation on cognitive performanceCognitive declinePsychiatryEpisodic memoryBiological PsychiatryAgedFirst episodePsychiatric Status Rating ScalesAnalysis of VarianceCognitionMiddle AgedVerbal Learningmedicine.diseasePsychiatry and Mental healthSchizophreniaDisease ProgressionSchizophreniaFemaleSchizophrenic PsychologyPsychologyCognition DisordersClinical psychologySchizophrenia research
researchProduct

Straight gyrus morphology in first-episode schizophrenia-spectrum patients

2010

et al.

AdultMalePsychosisAdolescentFirst episode schizophreniaGyrus rectusYoung AdultmedicineImage Processing Computer-AssistedHumansBrain magnetic resonance imagingBiological PsychiatryPharmacologyFirst episodeCerebral CortexPsychiatric Status Rating ScalesAnalysis of VarianceBrain MappingConfoundingHealthy subjectsAnatomyMiddle Agedmedicine.diseaseMagnetic Resonance ImagingFirst-episode schizophreniaStraight gyrusStraight gyrusSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologyNeuroscienceMRI
researchProduct

MOESM1 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 1. Full strategy in PubMed/MEDLINE.

3. Good health
researchProduct

Psychometric behaviour of the strengths and difficulties questionnaire (SDQ) in the Spanish national health survey 2006

2013

Abstract Background The Strengths and Difficulties Questionnaire (SDQ) is a tool to measure the risk for mental disorders in children. The aim of this study is to describe the diagnostic efficiency and internal structure of the SDQ in the sample of children studied in the Spanish National Health Survey 2006. Methods A representative sample of 6,773 children aged 4 to 15 years was studied. The data were obtained using the Minors Questionnaire in the Spanish National Health Survey 2006. The ROC curve was constructed and calculations made of the area under the curve, sensitivity, specificity and the Youden J indices. The factorial structure was studied using models of exploratory factorial ana…

MaleExternalizationPsychometricsAdolescentPsychometricsSample (statistics)Sensitivity and SpecificityGoodness of fitSurveys and QuestionnairesmedicineHumansChildReliability (statistics)Factor analysisMental DisordersReproducibility of ResultsStrengths and Difficulties Questionnairemedicine.diseaseHealth surveyHealth SurveysMental disorders diagnosed in childhoodPsychiatry and Mental healthSpainChild PreschoolFemaleEnfermeríaStrengths and difficulties questionnaireMental disorders diagnosed in childhoodPsychologyClinical psychologyResearch Article
researchProduct

Additional file 1: of Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of…

2017

PRISMA-P Checklist (DOCX 27 kb)

3. Good health
researchProduct

Additional file 1: of Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity diso…

2017

PRISMA-P checklist. (DOCX 24 kb)

3. Good health
researchProduct

MOESM4 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 4. List of PMID for included articles.

Data_FILESGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)3. Good health
researchProduct

Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder

2009

Abstract Background The relevance of persistent cognitive deficits to the pathogenesis and prognosis of bipolar disorders (BD) is understudied, and its translation into clinical practice has been limited by the absence of brief methods assessing cognitive status in Psychiatry. This investigation assessed the psychometric properties of the Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) for the detection of cognitive impairment in BD. Methods After short training, psychiatrists at 40 outpatient clinics administered the SCIP three times over two weeks to a total of 76 consecutive type I BD admissions. Experienced psychologists also administered a comprehensive ba…

AdultMalemedicine.medical_specialtyBipolar DisorderPsychometricsAdolescentPsychometricslcsh:Computer applications to medicine. Medical informaticsAmbulatory Care FacilitiesSensitivity and SpecificityYoung AdultCognitionQuality of lifemedicineManic-depressive illnessOutpatient clinicHumansBipolar disorderPsychiatryTrastorn bipolarResearchNeuropsychologyPublic Health Environmental and Occupational HealthConstruct validityReproducibility of ResultsCognitionGeneral MedicineMiddle Agedmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersLogistic ModelsROC CurveSpainCase-Control StudiesCogniciólcsh:R858-859.7FemalePsicometriaPsychologyCognition DisordersNeurocognitiveClinical psychologyHealth and Quality of Life Outcomes
researchProduct

P-1294 - Utility of the world health organization disability assessment schedule II in schizophrenia

2012

Aim The World Health Organization Disability Assessment Schedule II (WHODAS II) was developed for assessing disability. This study provides data on the validity and utility of the Spanish version of the WHODAS II in a large sample of patients with schizophrenia. Methods The sample included 352 patients with a schizophrenia spectrum disorder. They completed a comprehensive assessment battery including measures of psychopathology, functionality and quality-of-life. A sub-sample of 36 patients was retested after six months to assess its temporal stability. Results Participation in society (6.3%) and Life activities (4.0%) were the domains with the highest percentage of missing data. The intern…

medicine.medical_specialtyIntraclass correlationContext (language use)Missing datamedicine.diseaseMental healthPsychiatry and Mental healthCronbach's alphaSchizophreniaScale (social sciences)medicinePsychiatryPsychologyClinical psychologyPsychopathologyEuropean Psychiatry
researchProduct

Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019

2022

Correction to Lancet Public Health 2022; 7: e657-69. Lancet Public Health. 2022 Dec;7(12):e992. doi: 10.1016/S2468-2667(22)00294-8. PMID: 36462522. Background: Globally, transport and unintentional injuries persist as leading preventable causes of mortality and morbidity for adolescents. We sought to report comprehensive trends in injury-related mortality and morbidity for adolescents aged 10-24 years during the past three decades. Methods: Using the Global Burden of Disease, Injuries, and Risk Factors 2019 Study, we analysed mortality and disability-adjusted life-years (DALYs) attributed to transport and unintentional injuries for adolescents in 204 countries. Burden is reported in absolut…

MaleAdolescentRJ101AdolescentsGlobal Burden of DiseaseLife ExpectancyRJ101 Child Health. Child health servicesSDG 3 - Good Health and Well-beingRA0421Risk FactorsRA0421 Public health. Hygiene. Preventive MedicineHumansMortalityChildrenInterventionsMCCUnintentional injuriesPreventionPublic Health Environmental and Occupational Health3rd-DASGBD 2019 Adolescent Transport and Unintentional Injuries Collaborators3142 Public health care science environmental and occupational healthAdolescent transportPreventable causesHealthFemaleQuality-Adjusted Life YearsInvestmentMorbidityAdolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019The Lancet Public Health
researchProduct

Additional file 2: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

Key terms for PubMed/MEDLINE search. (DOCX 22 kb)

3. Good health
researchProduct

Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-d…

2017

BACKGROUND: Autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) are childhood onset neurodevelopmental disorders that may persist into adulthood. ASD and ADHD tend to run in families and may have a significant negative impact on the health and longevity of those with the disorder and their relatives. The aim of this study will be to analyze the risk of mortality among children, adolescents, and adults with ASD or ADHD and their first-degree relatives. METHODS/DESIGN: We will conduct a systematic review and meta-analysis of observational studies. Searches of PubMed/MEDLINE, EMBASE, PsycINFO, SCOPUS, and ISI Web of Science will be used to identify epidemiologica…

Research designMaleEpidemiologyAutism Spectrum DisorderMedicine (miscellaneous)lcsh:MedicineTrastorns de l'atencióAdolescents0302 clinical medicineCause of DeathRisk of mortalityProtocol030212 general & internal medicineChildChild developmentNeurodevelopmental disordersAutism spectrum disorders3. Good healthAutism spectrum disorderResearch DesignMeta-analysisFemaleInfantsCohort studyAdultRiskmedicine.medical_specialtyAdolescentAttention deficit hyperactivity disorder03 medical and health sciencesBibliometriamental disordersmedicineMortalitatAttention deficit hyperactivity disorderAdultsHumansFamilyFirst-degree relativesMortalityPsychiatrybusiness.industrylcsh:Rmedicine.diseaseMeta-analysisAttention Deficit Disorder with HyperactivitySystematic reviewObservational studyAutismebusiness030217 neurology & neurosurgerySystematic Reviews as Topic
researchProduct

Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Devel…

2020

BACKGROUND: Sustainable Development Goal (SDG) 3 aims to "ensure healthy lives and promote well-being for all at all ages". While a substantial effort has been made to quantify progress towards SDG3, less research has focused on tracking spending towards this goal. We used spending estimates to measure progress in financing the priority areas of SDG3, examine the association between outcomes and financing, and identify where resource gains are most needed to achieve the SDG3 indicators for which data are available. METHODS: We estimated domestic health spending, disaggregated by source (government, out-of-pocket, and prepaid private) from 1995 to 2017 for 195 countries and territories. For …

Economic growthFinancing GovernmentPsychological interventionHIV Infectionsburden of disease030204 cardiovascular system & hematologyDISEASEALLOCATION0302 clinical medicineRA0421RA0421 Public health. Hygiene. Preventive MedicineSustainable developmentGlobal healthhealth economicsHealthcare FinancingHIV Infection030212 general & internal medicine10. No inequality11 Medical and Health SciencesDALYHealthy lives1. No povertyPublic Health Global Health Social Medicine and Epidemiology3rd-DASGeneral MedicineSustainable Development3. Good healthtuberculosisIMPOVERISHMENTTERRITORIESFinancingHumanFinancing PersonalResource (biology)Tuberculosi195 COUNTRIESDeveloping Countrie03 medical and health sciencesSDG 3 - Good Health and Well-beingAcquired immunodeficiency syndrome (AIDS)General & Internal MedicineSYSTEMATIC ANALYSISmedicineHumansBurden HIV/AIDS tubercolosis malariaHuman resourcesDeveloping CountriesSustainable developmentGovernmentAcquired Immunodeficiency SyndromeHealth economicsbusiness.industryDISABILITYCATASTROPHEGlobal Burden of Disease Health Financing Collaborator NetworkGLOBAL BURDENmedicine.diseaseMalariaSDG; health sector spending; development assistant for health.Health ExpenditureFolkhälsovetenskap global hälsa socialmedicin och epidemiologi3121 General medicine internal medicine and other clinical medicineNAHealth ExpendituresbusinessEXPENDITURE
researchProduct

Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17.

2020

Background: Universal access to safe drinking water and sanitation facilities is an essential human right, recognised in the Sustainable Development Goals as crucial for preventing disease and improving human wellbeing. Comprehensive, high-resolution estimates are important to inform progress towards achieving this goal. We aimed to produce highresolution geospatial estimates of access to drinking water and sanitation facilities. Methods: We used a Bayesian geostatistical model and data from 600 sources across more than 88 low-income and middle-income countries (LMICs) to estimate access to drinking water and sanitation facilities on continuous continent-wide surfaces from 2000 to 2017, and…

Drinking water accessSanitationUniversal designGeographic MappingSocioeconomic FactorDISEASE0302 clinical medicineRA0421Hygiene11. SustainabilityGlobal health030212 general & internal medicineSanitationmedia_common2. Zero hungerPublic healthlcsh:Public aspects of medicine1. No povertyGeneral Medicine3142 Public health care science environmental and occupational health6. Clean waterLow-income countries3. Good healthA990 Medicine and Dentistry not elsewhere classifiedCHILD GROWTHTERRITORIESHYGIENEHuman0605 MicrobiologyDiarrheaAFRICAmedicine.medical_specialtymedia_common.quotation_subject030231 tropical medicineLocal Burden of Disease WaSH CollaboratorsDeveloping countryArticleGeographical inequalities1117 Public Health and Health Services12. Responsible consumptionDeveloping Countrie03 medical and health sciencesNUTRITIONAL INTERVENTIONSEnvironmental healthmedicineSYSTEMATIC ANALYSISHumansQUALITYSanitation/statistics & numerical dataOpen defecationImproved sanitationhand washingDeveloping CountriesModels StatisticalMiddle-income countriesDrinking WaterPublic healthlcsh:RA1-1270Bayes TheoremGLOBAL BURDENdiarrheal diseaseDIARRHEADiarrhea/epidemiologyLocal Burden of Disease WaSH CollaboratorSocioeconomic Factors0605 Microbiology 1117 Public Health and Health ServicesITC-ISI-JOURNAL-ARTICLEBusinessHuman medicineSanitation facilitiesITC-GOLD
researchProduct

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review wi…

2017

Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed psychiatric disorders in childhood. A wide variety of treatments have been used for the management of ADHD. We aimed to compare the efficacy and safety of pharmacological, psychological and complementary and alternative medicine interventions for the treatment of ADHD in children and adolescents. Methods and findings We performed a systematic review with network meta-analyses. Randomised controlled trials (≥ 3 weeks follow-up) were identified from published and unpublished sources through searches in PubMed and the Cochrane Library (up to April 7, 2016). Interventions of interest were pharmacolo…

Complementary TherapiesMaleTrastorns de l'atencióPoison controllcsh:MedicineMathematical and Statistical Techniques0302 clinical medicineBehavior TherapyMedicine and Health SciencesMedicine030212 general & internal medicineChildlcsh:ScienceRandomized Controlled Trials as TopicMultidisciplinaryPharmaceuticsMethylphenidate3. Good healthGuanfacineAntidepressant Drug TherapyNeurologyTolerabilityBehavioral PharmacologyResearch DesignPhysical SciencesFemaleStatistics (Mathematics)Research Articlemedicine.drugNeurological Drug Therapymedicine.medical_specialtyAdolescentClinical Research DesignNeuropsychiatric DisordersResearch and Analysis MethodsPlacebo03 medical and health sciencesDevelopmental NeuroscienceDrug TherapyInternal medicineMental Health and PsychiatryHumansAttention deficit hyperactivity disorderPsiquiatriaStatistical MethodsAdverse effectPsychiatryPharmacologyBehaviorbusiness.industryAtomoxetinelcsh:RCentral Nervous System DepressantsBiology and Life Sciencesmedicine.diseaseAttention Deficit Disorder with HyperactivityNeurodevelopmental DisordersCentral Nervous System StimulantsAdhdlcsh:QAdverse EventsbusinessMental Health TherapiesMathematics030217 neurology & neurosurgeryNeuroscienceMeta-AnalysisPLoS ONE
researchProduct

Direct and Inverse Comorbidities Between Complex Disorders

2016

Comorbidity and multimorbidity, defined as the presence of more than one disease in individuals, have emerged as a major challenge in the last decade (Valderas et al., 2009). Indeed, researchers, health professionals, healthcare managers and policy makers, and patients and citizens are lagging behind considering the comorbidity scenario, as illustrated by the paucity of documentation concerning interventions in people with multiple conditions (Smith et al., 2012). There is a clear need to better understand disease-disease relationships, in order to better organize and provide care, but also to develop appropriate research models. We can first characterize direct multimorbidity (higher-than-…

0301 basic medicineBiopsychosocial modelNosologymedicine.medical_specialtymedicinemultimorbidityPhysiologymalaltiesContext (language use)Disease03 medical and health sciencesPhysiology (medical)MultimorbidityMedicinecomplex diseasesPsychiatryOMICS dataComputingMilieux_MISCELLANEOUSbusiness.industrymedicine.diseaseComorbidity[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]3. Good healthcomorbidityEditorial030104 developmental biologyAge of onsetbusinessNeurocognitive
researchProduct

Predictors of neurocognitive impairment at 3years after a first episode non-affective psychosis

2013

Abstract Background Neurocognitive impairment is a core component of schizophrenia. However, patients show great variability in the level and course of deficits. The goal of the present longitudinal study was to identify predictors of neurocognitive impairment in first episode psychosis patients. Methods N eurocognitive performance was analyzed in a cohort of 146 patients 3 years after a first episode non-affective psychosis. Subgroups, impaired vs. unimpaired, were compared on baseline clinical, neuropsychological, premorbid and sociodemographic characteristics. Results Fifty-nine percent of participants presented general neurocognitive impairment and regression analyses demonstrated that …

AdultMalePsychosisAdolescentTrail Making TestPoison controlNeuropsychological TestsYoung AdultMemoryPredictive Value of TestsmedicineHumansLongitudinal StudiesBiological PsychiatryIntelligence TestsPsychiatric Status Rating ScalesPharmacologyFirst episodeTrail Making TestWechsler ScalesNeuropsychologyMiddle AgedPrognosismedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychotic DisordersSocioeconomic FactorsMotor SkillsSchizophreniaSchizophreniaRegression AnalysisFemaleSchizophrenic PsychologyVerbal memoryCognition DisordersPsychologyNeurocognitiveFollow-Up StudiesClinical psychologyProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIP…

2016

Introduction: Mild cognitive impairment (MCI) is a term used to describe a level of decline in cognition which is seen as an intermediate stage between normal ageing and dementia, and which many consider to be a prodromal stage of neurodegeneration that may become dementia. That is, it is perceived as a high risk level of cognitive change. The increasing burden of dementia in our society, but also our increasing understanding of its risk factors and potential interventions, require diligent management of MCI in order to find strategies that produce effective prevention of dementia. Aim: To update knowledge regarding mild cognitive impairment, and to bring together and appraise evidence abou…

GerontologyAgingConsensusRisk factors in diseases:Medicina Básica [Ciências Médicas]Psychological interventionPosition statementPrevention of dementiaGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineCognitionRisk FactorsEnvellimentTerminology as TopicIntervention (counseling)Mild cognitive declinemental disordersPrevalenceHumansMedicineDementiaPsychologyCognitive DysfunctionProspective Studies030212 general & internal medicineCognitive declineDemènciaScience & TechnologyCognitive frailtybusiness.industryFactors de risc en les malaltiesProdromal StageObstetrics and GynecologyCognitionmedicine.diseasePsicologiaCiências Médicas::Medicina BásicaCognicióDisease ProgressionTrastorns de la memòria en la vellesaDementiabusiness030217 neurology & neurosurgeryIndependent living
researchProduct

Health effects of overweight and obesity in 195 countries over 25 years

2017

Source at: http://doi.org/10.1056/NEJMoa1614362 Background: Although the rising pandemic of obesity has received major attention in many countries, the effects of this attention on trends and the disease burden of obesity remain uncertain. Methods: We analyzed data from 68.5 million persons to assess the trends in the prevalence of overweight and obesity among children and adults between 1980 and 2015. Using the Global Burden of Disease study data and methods, we also quantified the burden of disease related to high body-mass index (BMI), according to age, sex, cause, and BMI in 195 countries between 1990 and 2015. Restults: In 2015, a total of 107.7 million children and 603.7 million adult…

MaleGerontologyPediatric ObesityobesityVDP::Medisinske Fag: 700::Helsefag: 800::Epidemiologi medisinsk og odontologisk statistikk: 803global healthDiseaseOverweightGlobal HealthVDP::Social science: 200::Demography: 300DISEASEVDP::Medical disciplines: 700::Health sciences: 800::Nutrition: 811Body Mass Index0302 clinical medicineRA0421PandemicPrevalenceadultsGlobal health030212 general & internal medicineChildhumansALL-CAUSE MORTALITYchildadult1. No povertypediatric obesity/epidemiology11 Medical And Health SciencesGeneral MedicineCANCER3. Good healthfemaleVDP::Medical disciplines: 700::Health sciences: 800::Epidemiology medical and dental statistics: 803Cardiovascular DiseasesCohortFemalemedicine.symptomLife Sciences & BiomedicineobesitatResearch ArticleAdultprevalenceoverweight/complications/epidemiologyWEIGHT-LOSS030209 endocrinology & metabolismKNEE OSTEOARTHRITISVDP::Samfunnsvitenskap: 200::Demografi: 300VDP::Medisinske Fag: 700::Helsefag: 800::Ernæring: 81103 medical and health sciencescardiovascular diseases/complications/mortalityMedicine General & InternalchildrenmaleGeneral & Internal MedicineEnvironmental healthmedicineHumansoverweightCOHORTObesityDisease burdenMETAANALYSISScience & TechnologyGBD 2015 Obesity Collaboratorsbusiness.industryADULTSOverweightmedicine.diseaseObesityPREVENTIONBODY-MASS INDEXCross-Sectional StudiesbusinessBody mass indexobesity/complications/*epidemiology
researchProduct

Additional file 1: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

PRISMA-P Checklist. (DOCX 27 kb)

3. Good health
researchProduct

Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up

2007

Abstract Objective Many studies have reported that cognitive ability may be predictive of the functional outcome for patients with schizophrenia. However, no study has prospectively examined these aspects in schizophrenia and bipolar disorders simultaneously. The present study attempted to analyze if neurocognition and clinical status predicts the real-life functioning for patients with schizophrenia or bipolar I disorder, using a longitudinal design. Method Forty-seven schizophrenic and 43 bipolar I outpatients were assessed twice with a neurocognitive battery (Executive Functions, Working Memory, Verbal Memory, Visual Memory, Visual-Motor Processing, Vigilance, Vocabulary and Motor Speed …

Malemedicine.medical_specialtyBipolar DisorderBipolar I disorderGlobal Assessment of FunctioningSeverity of Illness IndexDisability EvaluationYoung AdultPredictive Value of Testsmental disordersmedicineHumansProspective StudiesBipolar disorderPsychiatryDemographyWechsler ScalesNeuropsychologyHamilton Rating Scale for Depressionmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologySchizophreniaFemaleVerbal memorymedicine.symptomCognition DisordersPsychologyNeurocognitiveManiaFollow-Up StudiesJournal of Affective Disorders
researchProduct

Additional file 2: of Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of…

2017

Key terms for PubMed/MEDLINE search (DOCX 22 kb)

3. Good health
researchProduct

Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer.

2009

Defects in genetic and developmental processes are thought to contribute susceptibility to autism and schizophrenia. Presumably, owing to etiological complexity identifying susceptibility genes and abnormalities in the development has been difficult. However, the importance of genes within chromosomal 8p region for neuropsychiatric disorders and cancer is well established. There are 484 annotated genes located on 8p; many are most likely oncogenes and tumor-suppressor genes. Molecular genetics and developmental studies have identified 21 genes in this region (ADRA1A, ARHGEF10, CHRNA2, CHRNA6, CHRNB3, DKK4, DPYSL2, EGR3, FGF17, FGF20, FGFR1, FZD3, LDL, NAT2, NEF3, NRG1, PCM1, PLAT, PPP3CC, S…

GeneticsPsychosismedicine.medical_specialtyGene Expression Regulation DevelopmentalDiseasemedicine.diseaseDevelopmental disorderCellular and Molecular NeurosciencePsychiatry and Mental healthSchizophreniaMolecular geneticsNeoplasmsBehavioral medicinemedicineSchizophreniaAutismAnimalsHumansBipolar disorderAutistic DisorderPsychologyMolecular BiologyNeuroscienceChromosomes Human Pair 8Molecular psychiatry
researchProduct

Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardi…

2014

Data on the long-term metabolic side-effects associated with antipsychotics are scarce. Prospective longitudinal studies in medication-naive patients with a first episode of psychosis are a valuable source of information as they provide an assessment prior to the antipsychotic exposure and minimize the effect of potential confounding factors. The aim of this study was to assess the course of weight gain and the incidence of metabolic abnormalities during the first 3 yr of antipsychotic treatment. Data were collected from a cohort of 170 first-episode psychosis patients. They were randomly assigned to haloperidol (32%); olanzapine (32%) and risperidone (36%). The dose used was flexible. The …

OlanzapineAdultMaleMedication-naivemedicine.medical_specialtyTime FactorsAdolescentmedicine.medical_treatmentWeight GainBenzodiazepinesYoung AdultMetabolic DiseasesRisk FactorsMetabolic side effectsInternal medicinemedicineHumansAntipsychoticsPharmacology (medical)Prospective StudiesAntipsychoticPsychiatryProspective cohort studyPharmacologyFirst episodeRisperidoneMiddle AgedRisperidoneFirst-episode psychosisCardiovascular riskCritical periodPsychiatry and Mental healthTolerabilityPsychotic DisordersOlanzapineCohortHaloperidolmedicine.symptomPsychologyWeight gainmedicine.drugAntipsychotic Agents
researchProduct

Disability in bipolar I disorder: the 36-item World Health Organization Disability Assessment Schedule 2.0.

2014

Abstract Background The WHODAS 2.0 is an ICF-based multidimensional instrument developed for measuring disability. The present study analyzes the utility of the 36-item interviewer-administered version in a sample of patients with bipolar disorder. There is no study to date that analyses how the scale works in a sample that only comprises such patients. Methods A total of 291 patients with bipolar disorder (42.6% males) according to DSM-IV-TR criteria from a cross-sectional study conducted in outpatient psychiatric clinics were enrolled. In addition to the WHODAS 2.0, patients completed a comprehensive assessment battery including measures on psychopathology, functionality and quality of li…

AdultMalemedicine.medical_specialtyBipolar I disorderActivities of daily livingBipolar DisorderPsychometricsPsychological interventionWorld Health OrganizationDisability EvaluationQuality of life (healthcare)Cronbach's alphaActivities of Daily LivingmedicineHumansDisabled PersonsBipolar disorderPsychiatryReproducibility of ResultsMiddle Agedmedicine.diseaseSelf CarePsychiatry and Mental healthClinical PsychologyMoodCross-Sectional StudiesQuality of LifeFemalePsychologyPsychopathologyClinical psychologyJournal of affective disorders
researchProduct

Additional file 3: of Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of ob…

2019

Methodological Quality Checklist for Prevalence data. (DOCX 28 kb)

3. Good health
researchProduct

MOESM6 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 6. Exploratory analysis of topical data.

Data_FILES3. Good health
researchProduct

Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies

2017

[Background] The objective of this study will be to synthesize the epidemiological evidence and evaluate the validity of the associations between central nervous system disorders and the risk of developing or dying from cancer.

Research designAnorexia NervosaBipolar DisorderMedicine (miscellaneous)lcsh:MedicineDisease0302 clinical medicineDown’s syndromeCentral Nervous System DiseasesNeoplasmsProtocolMedicine030212 general & internal medicineCàncerCancerDepressionIncidenceHuntington’sdiseaseAnorèxia nerviosaAutism spectrum disorders3. Good healthObservational Studies as TopicSystematic reviewResearch DesignMeta-analysisEsquizofrèniaAlzheimer’s diseaseHuntington’s diseasemedicine.medical_specialtyCentral nervous system disorderMultiple SclerosisBipolar disorderSistema nerviós central MalaltiesMEDLINEMultiple sclerosisParkinson’s Disease03 medical and health sciencesMeta-Analysis as TopicDown’s SyndromeHuntington’s DiseaseHumansAlzheimer’s DiseasePsychiatryIntensive care medicineEpilepsybusiness.industrylcsh:RAmyotrophic Lateral SclerosisCancerCentral Nervous System DisorderAnorexia nervosamedicine.diseaseAmyotrophic lateral sclerosisMeta-analysisReview Literature as TopicParkinson’s diseaseSystematic reviewSchizophreniaObservational Studies as TopicObservational studySystematic ReviewAutismebusiness030217 neurology & neurosurgerySystematic Reviews as TopicMeta-Analysis
researchProduct

Subjective neurocognition and quality of life in patients with bipolar disorder and siblings.

2018

Abstract Background Bipolar disorder (BD) is associated with significant neurocognitive and functional impairment, which may progress across stages. However, the potential progression of subjective cognitive complaints and quality of life (QoL) has not been addressed. Our main objective was to assess subjective cognitive complaints and QoL on euthymic patients with BD and their healthy siblings. Methods Four groups were compared: euthymic patients with type I BD in the early (n = 25) and late (n = 23) stages, their healthy siblings (latent stage; n = 23) and healthy controls (n = 21). Cognitive complaints and QoL were assessed using the COBRA and WHO-QoLBREF questionnaires, respectively. Re…

AdultMaleFunctional impairmentBipolar Disorder03 medical and health sciences0302 clinical medicineCognitionQuality of lifeSurveys and QuestionnairesmedicineHumansIn patientBipolar disorderbusiness.industrySiblingsCognitionMiddle Agedmedicine.diseaseCyclothymic Disorder030227 psychiatryPsychiatry and Mental healthClinical PsychologyDisease ProgressionQuality of LifeFemalebusinessNeurocognitive030217 neurology & neurosurgeryClinical psychologyJournal of affective disorders
researchProduct

The increasing burden of mental and neurological disorders.

2013

Pharmacologymedicine.medical_specialtybusiness.industryMental DisordersMEDLINEPsychiatry and Mental healthText miningNeurologyCost of IllnessmedicineCost of illnessHumansPharmacology (medical)Neurology (clinical)Nervous System DiseasesbusinessIntensive care medicineBiological PsychiatryEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Unveiling the molecular basis of disease co-occurrence: towards personalized comorbidity profiles

2018

AbstractComorbidity is an impactful medical problem that is attracting increasing attention in healthcare and biomedical research. However, little is known about the molecular processes leading to the development of a specific disease in patients affected by other conditions. We present a disease interaction network inferred from similarities in patients’ molecular profiles, which significantly recapitulates epidemiologically documented comorbidities, providing the basis for their interpretation at a molecular level. Furthermore, expanding on the analysis of subgroups of patients with similar molecular profiles, our approach discovers comorbidity relations not previously described, implicat…

Molecular levelbusiness.industryInteraction networkCo-occurrenceMedicineIn patientDiseaseComputational biologybusinessmedicine.diseaseComorbidity
researchProduct

EPA-0492 - Functional remediation in bipolar II patients: improvement of functioning and subsyndromal symptoms

2014

Introduction Recently, Functional Remediation (FR) has proven to be effective in improving the functional outcome of euthymic bipolar patients. Objective Our objective was to test the efficacy of FR programme in a subsample of euthymic bipolar II patients (BPII). Aims The main aim was improve the functional outcome in these patients. Method Post-hoc analyses were undertaken using data of 53 DSM-IV diagnosed BPII outpatients who had participated in a multicentre, rater blind, randomized, controlled trial (RCT) exploring the efficacy of FR (n=17) as compared with a Psychoeducation (PSY) (n=19) and a control (n=17) groups which only treatment as usual (TAU). The primary outcome variable was a …

Psychiatry and Mental healthmedicine.medical_specialtyPrimary outcomeRandomized controlled triallawmedicine.medical_treatmentInternal medicinePsychoeducationmedicineTreatment as usualPsychologyClinical psychologylaw.inventionEuropean Psychiatry
researchProduct

Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study …

2022

Background: The health risks associated with moderate alcohol consumption continue to be debated. Small amounts of alcohol might lower the risk of some health outcomes but increase the risk of others, suggesting that the overall risk depends, in part, on background disease rates, which vary by region, age, sex, and year. Methods: For this analysis, we constructed burden-weighted dose-response relative risk curves across 22 health outcomes to estimate the theoretical minimum risk exposure level (TMREL) and non-drinker equivalence (NDE), the consumption level at which the health risk is equivalent to that of a non-drinker, using disease rates from the Global Burden of Diseases, Injuries, and …

AdultMaleAlcohol DrinkingCONTROL POLICIESadult; Alcohol Drinking; Child Preschool; Female; Geography; Global Burden of Disease; Global Health; Humans; Male; Middle Aged; Quality-Adjusted Life Years; Risk FactorsNDASALL-CAUSEGUIDELINESGlobal HealthGBD 2020 Alcohol CollaboratorsGlobal Burden of DiseaseCOST-EFFECTIVENESSMedicine General & InternalDRINKINGSDG 3 - Good Health and Well-beingRA0421Risk FactorsGeneral & Internal MedicineQuality-Adjusted Life YearRA0421 Public health. Hygiene. Preventive MedicineDRINKERSHumansChildPreschool11 Medical and Health SciencesMETAANALYSISMCCScience & Technologyglobal burden of diseaseGeographyRisk FactoradultGeneral MedicineMiddle AgedCANCERalcohol drinkingACChild Preschool3121 General medicine internal medicine and other clinical medicineFemaleQuality-Adjusted Life YearsREDUCED MORTALITYLife Sciences & Biomedicinealcohol drinking; global burden of disease; adultHuman
researchProduct

The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review

2016

Open Access; Open Peer Review.-- et al.

Research designCost effectivenessCost-Benefit AnalysisMEDLINEMedicine (miscellaneous)030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineCentre for Reviews and DisseminationEnvironmental healthHumansMedicineQuality-adjusted life years030212 general & internal medicineProtocol (science)Cost–utility analysisbusiness.industryResearchCost-effectiveness analysisCost-utility analysisMethodologyCost-effectiveness analysis3. Good healthQuality-adjusted life yearReportingResearch DesignSpainbusinessDelivery of Health CareSystematic Reviews
researchProduct

Postnatal alterations of the inhibitory synaptic responses recorded from cortical pyramidal neurons in the Lis1/sLis1 mutant mouse

2006

Mutations in the mouse Lis1 gene produce severe alterations in the developing cortex. We have examined some electrophysiological responses of cortical pyramidal neurons during the early postnatal development of Lis/sLis1 mutant mice. In P7 and P30 Lis1/sLis1 neurons we detected a lower frequency and slower decay phase of mIPSCs, and at P30 the mIPSCs amplitude and the action potential duration were reduced. Zolpidem (an agonist of GABAA receptors containing the alpha1 subunit) neither modified the amplitude nor the decay time of mIPSCs at P7 in Lis1/sLis1 neurons, whereas it increased the decay time at P30. The levels of GABAA receptor alpha1 subunit mRNA were reduced in the Lis1/sLis1 brai…

Agonistmedicine.medical_specialtyZolpidemPyridinesmedicine.drug_classAction PotentialsIn Vitro TechniquesBiologyInhibitory postsynaptic potentialMiceCellular and Molecular NeuroscienceInternal medicinemedicineAnimalsReceptorGABA AgonistsMolecular BiologyCerebral CortexReverse Transcriptase Polymerase Chain ReactionGABAA receptorPyramidal CellsAge FactorsGene Expression Regulation DevelopmentalCell BiologyElectric StimulationMice Mutant StrainsCortex (botany)ZolpidemElectrophysiologymedicine.anatomical_structureEndocrinologyAnimals NewbornInhibitory Postsynaptic Potentialsnervous systemCerebral cortex1-Alkyl-2-acetylglycerophosphocholine EsteraseMicrotubule-Associated Proteinsmedicine.drugMolecular and Cellular Neuroscience
researchProduct

Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the G…

2022

Background: Experimental and epidemiological studies indicate an association between exposure to particulate matter (PM) air pollution and increased risk of type 2 diabetes. In view of the high and increasing prevalence of diabetes, we aimed to quantify the burden of type 2 diabetes attributable to PM2·5 originating from ambient and household air pollution.Methods: We systematically compiled all relevant cohort and case-control studies assessing the effect of exposure to household and ambient fine particulate matter (PM2·5) air pollution on type 2 diabetes incidence and mortality. We derived an exposure–response curve from the extracted relative risk estimates using the MR-BRT (meta-regress…

Contaminación del AireHealth (social science)Type II DiabetesType 2 diabetes deathsair pollutionand YLLs attributable to all PM2·5 air pollutionMedicine (miscellaneous)and change from 1990 to 2019DALYsburden of diseaseGlobal Burden of DiseaseCarga Global de EnfermedadesMELLITUSINFLAMMATIONand household PM2·5 pollution from solid fuels in seven GBD super-regions and globally in 2019Diabetes MellitusHumansBiologyASSOCIATIONSRISKINSULIN-RESISTANCEGBD 2019 Diabetes and Air Pollution CollaboratorsHealth PolicyMaterial ParticuladoPublic Health Environmental and Occupational HealthBayes TheoremLONG-TERM EXPOSUREHumanosYLDsChemistryDiabetes Mellitus Type 23121 General medicine internal medicine and other clinical medicineAños de Vida Ajustados por Calidad de Vidaambient PM2·5 pollutionParticulate MatterQuality-Adjusted Life YearsHuman medicineFINE PARTICULATE MATTERRAType II Diabetes; air pollution; burden of disease;The Lancet Planetary Health
researchProduct

Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.

2012

Abstract Background Imaging evidence indicates that brain alterations are primary to the full-blown onset of schizophrenia and seem to progress across time. The potential effects of antipsychotic medication on brain structure represent a key factor in understanding brain changes in psychosis. We aimed to investigate the effects of low doses of haloperidol, risperidone and olanzapine on cortical thickness. Method We investigated the effects of risperidone (N = 16), olanzapine (N = 18) and low doses of haloperidol (N = 18) in cortical thickness changes during 1-year follow-up period in a large and heterogeneous sample of schizophrenia spectrum patients. The relationship between cortical thick…

OlanzapineAdultMalemedicine.medical_specialtyPsychosisAdolescentmedicine.medical_treatmentNeuropsychological TestsBenzodiazepinesYoung AdultDouble-Blind MethodInternal medicinemedicineHaloperidolImage Processing Computer-AssistedHumansAntipsychoticScale for the Assessment of Negative SymptomsBiological PsychiatryAgedRetrospective StudiesCerebral CortexPsychiatric Status Rating ScalesAnalysis of VarianceRisperidoneVoxel-based morphometryMiddle Agedmedicine.diseaseRisperidoneMagnetic Resonance ImagingPsychiatry and Mental healthEndocrinologyFrontal lobeOlanzapineSchizophreniaHaloperidolFemalePsychologyCognition Disordersmedicine.drugClinical psychologyAntipsychotic AgentsFollow-Up StudiesSchizophrenia research
researchProduct

Mapping disparities in education across low- and middle-income countries

2020

Educational attainment is an important social determinant of maternal, newborn, and child health1–3. As a tool for promoting gender equity, it has gained increasing traction in popular media, international aid strategies, and global agenda-setting4–6. The global health agenda is increasingly focused on evidence of precision public health, which illustrates the subnational distribution of disease and illness7,8; however, an agenda focused on future equity must integrate comparable evidence on the distribution of social determinants of health9–11. Here we expand on the available precision SDG evidence by estimating the subnational distribution of educational attainment, including the proporti…

MaleATTAINMENTHealth StatusDiseaseeducation; low- and middle-income countries0302 clinical medicineWORLDgenderGlobal healthrisk factors030212 general & internal medicineAetiology10. No inequalitymedia_commonDeveloping worldPediatricMultidisciplinaryR1. No povertyMultidisciplinary SciencesGeographyScience & Technology - Other TopicsFemaleHEALTHdeveloping worldsocial and economic factorsEngineering sciences. TechnologydisparitieAFRICAmedicine.medical_specialty330InequalityGeneral Science & Technologymedia_common.quotation_subjectMODELSDeveloping countryLocal Burden of Disease Educational Attainment CollaboratorsArticleHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]Education03 medical and health sciences2.3 PsychologicalmedicineHumansSocietySocial determinants of healthDeveloping CountriesScience & TechnologyEquity (economics)MORTALITYPublic healthBayes TheoremEducational attainment3141 Health care sciencesocietyGood Health and Well BeingRisk factorsSocioeconomic FactorsDemographic economics030217 neurology & neurosurgery
researchProduct

Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.

2009

Few studies have compared neurocognitive performance in euthymic patients with bipolar disorder (BD), stabilized patients with schizophrenia (SC) and normal controls (NC) using a comprehensive neuropsychological battery, and those that have been conducted have yielded discrepant results. We evaluated the neurocognitive profile shown by 73 euthymic patients with BD, 89 stabilized patients with SC and 67 NC. All participants completed a cognitive battery in which the domains evaluated were executive functioning, sustained attention, and verbal and visual memory. Individuals with BD were administered the Quality of Life Scale (QLS). Patients with BD manifested dysfunction in executive function…

AdultMalemedicine.medical_specialtyBipolar DisorderAdolescentGlobal Assessment of FunctioningTrail Making TestAudiologyNeuropsychological TestsYoung AdultVisual memoryMemorymedicineMemory spanHumansPsychiatryBiological PsychiatryProblem SolvingPsychiatric Status Rating ScalesCalifornia Verbal Learning TestChi-Square DistributionMiddle Agedmedicine.diseasePsychiatry and Mental healthSchizophreniaMultivariate AnalysisSchizophreniaFemaleSchizophrenic PsychologyVerbal memoryPsychologyCognition DisordersNeurocognitivePsychiatry research
researchProduct

Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features

2010

BackgroundThe thickness of the cortical mantle is a sensitive measure for identifying alterations in cortical structure. We aimed to explore whether first episode schizophrenia patients already show a significant cortical thinning and whether cortical thickness anomalies may significantly influence clinical and cognitive features.MethodWe investigated regional changes in cortical thickness in a large and heterogeneous sample of schizophrenia spectrum patients (n=142) at their first break of the illness and healthy controls (n=83). Magnetic resonance imaging brain scans (1.5 T) were obtained and images were analyzed by using brains2. The contribution of sociodemographic, cognitive and clinic…

AdultMalemedicine.medical_specialtyAdolescentbrainBrain mappingArticleYoung AdultCognitionCortex (anatomy)Internal medicineImage Processing Computer-AssistedmedicineHumansApplied PsychologyCerebral CortexPsychiatric Status Rating ScalesAnalysis of VarianceBrain Mappingmedicine.diagnostic_testAge FactorsMagnetic resonance imagingMiddle Agedcortical thicknessmedicine.diseaseMagnetic Resonance ImagingendophenotypeschizophreniaPsychiatry and Mental healthmedicine.anatomical_structureCerebral cortexSchizophreniaEndophenotypeCardiologyFemaleAnalysis of varianceAge of onsetPsychologyNeuroscienceMRIPsychological Medicine
researchProduct

Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

[Background]: Randomised controlled trials (RCTs) provide the most reliable information to inform clinical practice and patient care. We aimed to map global clinical research publication activity through RCT-related articles in high-impact-factor medical journals over the past five decades.

medicine.medical_specialtyEvidence-based medicineCross-sectional studyHigh impact factorMEDLINEMedicine (miscellaneous)030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicineHumansPharmacology (medical)030212 general & internal medicineRandomized Controlled Trials as Topiclcsh:R5-920business.industryResearchPublicationsEvidence-based medicinehumanities3. Good healthCross-Sectional StudiesClinical researchScientific collaborationPublishingRandomized controlled trialFamily medicineJournal Impact FactorPeriodicals as TopicbusinessCitationlcsh:Medicine (General)
researchProduct

Estimating global injuries morbidity and mortality

2020

Background. While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. Methods. In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then est…

MalePopulations/contexts1106 Human Movement and Sports SciencesGlobal injuriespopulation030204 cardiovascular system & hematologyGlobal HealthcontextscontextGlobal Burden of Disease0302 clinical medicineQuality-Adjusted Life YearGlobal health1506030212 general & internal medicineOriginal ResearchDatapopulations/contextsIncidence (epidemiology)Incidencemethodology3142 Public health care science environmental and occupational healthPeer reviewFemalePublic HealthTERRITORIESQuality-Adjusted Life Yearsdescriptive epidemiologyHumanDisabilities195 COUNTRIESstatistical issue1117 Public Health and Health Services03 medical and health sciencesAGELife ExpectancyEnvironmental healthInjury preventionSYSTEMATIC ANALYSISstatistical issuesHumansMortalityEstimationSEX-SPECIFIC MORTALITYDISABILITYPublic Health Environmental and Occupational Healthpopulations; contexts; methodology; descriptive epidemiology; statistical issues; Female; Humans; Incidence; Life Expectancy; Male; Morbidity; Quality-Adjusted Life Years; Global Burden of Disease; Global Health; Wounds and Injuriespopulations1106 Human Movement and Sports Sciences 1117 Public Health and Health Services 1701 PsychologyQuality-adjusted life yearYears of potential life lost1701 PsychologyLife expectancyEstimatesWounds and InjuriesHuman medicineMorbiditypopulations/contextInjury prevention
researchProduct

The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients

2013

Abstract Background The Screen for Cognitive Impairment in Psychiatry (SCIP) is a simple and easy to administer scale developed for screening cognitive deficits. This study presents the diagnostic-specific standardization data for this scale in a sample of schizophrenia and bipolar I disorder patients. Methods Patients between 18 and 55 years who are in a stable phase of the disease, diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or bipolar I disorder were enrolled in this study. Results The SCIP-S was administered to 514 patients (57.9% male), divided into two age groups (18–39 and 40–55 years) and two educational level groups (less than and secondary or…

AdultMalemedicine.medical_specialtyBipolar DisorderBipolar I disorderAdolescentNormsSchizoaffective disorderSCIP-SDiseaseNeuropsychological TestsYoung AdultCognitionmental disordersmedicineHumansBipolar I disorderBipolar disorderYoung adultSchizophreniform disorderPsychiatryLanguagePsychiatric Status Rating ScalesPsychiatrybusiness.industryReproducibility of ResultsCognitionMiddle Agedmedicine.diseaseStandardization dataPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaFemaleCognition DisordersbusinessResearch ArticleClinical psychologyBMC Psychiatry
researchProduct

Additional file 3: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

Definitions of specific cancer-site outcomes. (DOCX 27 kb)

3. Good health
researchProduct

Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Met…

2016

Background Medications aimed at inhibiting the renin–angiotensin system (RAS) have been used extensively for preventing cardiovascular and renal complications in patients with diabetes, but data that compare their clinical effectiveness are limited. We aimed to compare the effects of classes of RAS blockers on cardiovascular and renal outcomes in adults with diabetes. Methods and Findings Eligible trials were identified by electronic searches in PubMed/MEDLINE and the Cochrane Database of Systematic Reviews (1 January 2004 to 17 July 2014). Interventions of interest were angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and direct renin (DR) inhibitors. T…

ACE inhibitorsMyocardial InfarctionAngiotensin-Converting Enzyme Inhibitors030204 cardiovascular system & hematologyACE inhibitor therapyBiochemistryRenin-Angiotensin SystemAnginachemistry.chemical_compoundEndocrinologyMathematical and Statistical Techniques0302 clinical medicineReninMedicine and Health SciencesSecondary Prevention030212 general & internal medicineMyocardial infarctionDiureticsStrokePharmaceuticsRDrugsEnzyme inhibitorsCardiovascular therapyGeneral Medicine3. Good healthHospitalizationStrokeNephrologyCardiovascular DiseasesPhysical SciencesCardiologyMedicineDrug therapyStatistics (Mathematics)Research Articlemedicine.drugAdultmedicine.medical_specialtyEndocrine DisordersCardiologyResearch and Analysis MethodsAngina PectorisDiabetes ComplicationsAngiotensin Receptor Antagonists03 medical and health sciencesDiabetes mellitusInternal medicineRenal DiseasesDiabetes MellitusmedicineHumansStatistical MethodsRenal Insufficiency ChronicPharmacologyHeart FailureCreatinineBiology and life sciencesbusiness.industryOdds ratiomedicine.diseasechemistryMetabolic DisordersHeart failuresistema cardiovascularACE inhibitorEnzymologyKidney Failure ChronicbusinessMathematicsMeta-AnalysisPLOS Medicine
researchProduct

Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFI…

2013

Abstract Objective Predicting response to antipsychotic treatment might optimize treatment strategies in early phases of schizophrenia. We aimed to investigate sociodemographic, premorbid and clinical predictors of response to antipsychotic treatment after a first episode of non-affective psychosis. Method 375 (216 males) patients with a diagnosis of non affective psychosis entered the study. The main outcome measure was clinical response at 6 weeks and variables at baseline were evaluated as predictors of response. ANOVA for continuous and chi-square for categorical data were used to compare responders and non-responders. Multivariate logistic regression was used to establish a prediction …

AdultMalePsychosismedicine.medical_specialtyAdolescentLogistic regressionCohort StudiesYoung AdultPredictive Value of TestsOutcome Assessment Health CaremedicineHumansFamily historyPsychiatryBiological PsychiatryRetrospective StudiesPharmacologyFirst episodePsychiatric Status Rating ScalesAnalysis of VarianceChi-Square DistributionMiddle Agedmedicine.diseaseLogistic ModelsPsychotic DisordersSchizophreniaSpainCohortdupFemalePsychologyDiagnosis of schizophreniaAntipsychotic AgentsProgress in neuro-psychopharmacologybiological psychiatry
researchProduct

Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders

2013

Inverse comorbidity is a lower-than-expected probability of disease occuring in individuals who have been diagnosed with other medical conditions. Emerging evidence points to inverse cancer comorbidity in people with certain CNS disorders. In this Opinion article, we discuss the evidence for this intriguing association and possible underlying mechanisms. We believe that this association is an invaluable opportunity to gain insight into the pathogenesis of these diseases, and understanding why certain individuals with CNS disorders are protected against many different types of cancer could help to develop new and improved treatments.

medicine.medical_specialtybusiness.industryGeneral NeuroscienceMEDLINECancerComorbidityDiseasemedicine.diseaseComorbidityCentral Nervous System DiseasesNeoplasmsHumansMedicinebusinessPsychiatryNature Reviews Neuroscience
researchProduct

Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from th…

2020

Incluye: Correction: Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017. Inj Prev. 2020 Oct;26(Supp 1):i164. doi: 10.1136/injuryprev-2019-043296corr1. Epub 2020 Sep 28. PMID: 32989004 Background: The epidemiological transition of non-communicable diseases replacing infectious diseases as the main contributors to disease burden has been well documented in global health literature. Less focus, however, has been given to the relationship between sociodemographic changes and injury. The aim of this study was to examine the association between disability-adjuste…

Epidemiologyburden of disease; descriptive epidemiology; epidemiologyECONOMIC-DEVELOPMENT1106 Human Movement and Sports SciencesPoison controlburden of diseaseGlobal HealthGlobal Burden of Disease0302 clinical medicineQuality-Adjusted Life YearGlobal health030212 general & internal medicine10. No inequality1. No povertyBurden of diseaseDALYS3142 Public health care science environmental and occupational healthddc:3. Good healthDescriptive epidemiologyEpidemiological transitionREGISTRATIONDisabled PersonepidemiologyPublic Healthdescriptive epidemiologyHumanmedicine.medical_specialtyDEATHSAdolescent1117 Public Health and Health Services03 medical and health sciencesLife ExpectancyInjury preventionSYSTEMATIC ANALYSISmedicineDisability-adjusted life yearDisease burdenEstimationburden of disease descriptive epidemiology epidemiologyMORTALITYPublic healthEPIDEMIOLOGIC TRANSITIONPublic Health Environmental and Occupational Health030208 emergency & critical care medicineTRENDSEXPECTANCY HALE1701 PsychologyWounds and InjuriesHuman medicineDemography
researchProduct

Reporting guidelines for health research: protocol for a cross-sectional analysis of the EQUATOR Network Library

2019

© Author(s) (or their employer(s)) 2019.

Research ReportBiomedical ResearchCross-sectional studyeducationSpecialtyMEDLINEGuidelines as Topic03 medical and health sciences0302 clinical medicineProtocolHumansresearch reportingMedicine1506030212 general & internal medicinePublishingData abstractionMedical educationbusiness.industry1711General MedicineTransparency (behavior)AuthorshipChecklist3. Good healthReview Literature as TopicResearch NetworksResearch DesignMedical Publishing and Peer ReviewScientific CollaborationReporting GuidelinesResearch reportingCitationRaw databusinessNetwork Analysis030217 neurology & neurosurgeryBMJ Open
researchProduct

Additional file 3: of Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of ob…

2019

Methodological Quality Checklist for Prevalence data. (DOCX 28 kb)

3. Good health
researchProduct

The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study

2022

Abstract Background Injury remains a major concern to public health in the European region. Previous iterations of the Global Burden of Disease (GBD) study showed wide variation in injury death and disability adjusted life year (DALY) rates across Europe, indicating injury inequality gaps between sub-regions and countries. The objectives of this study were to: 1) compare GBD 2019 estimates on injury mortality and DALYs across European sub-regions and countries by cause-of-injury category and sex; 2) examine changes in injury DALY rates over a 20 year-period by cause-of-injury category, sub-region and country; and 3) assess inequalities in injury mortality and DALY rates across the countries…

Science & TechnologyInjuriesDEATHSPublic Health Environmental and Occupational HealthBurden of diseasePublic Health Global Health Social Medicine and Epidemiology3121 Internal medicineBurden of disease; Injuries; Disability adjusted life years; Mortality; Europe3142 Public health care science environmental and occupational health1117 Public Health and Health ServicesInjurieDisability adjusted life yearsEuropeFolkhälsovetenskap global hälsa socialmedicin och epidemiologiSDG 3 - Good Health and Well-beingINEQUALITIESPublic HealthHuman medicineDisability adjusted life yearMortalityLife Sciences & BiomedicinePublic Environmental & Occupational Health
researchProduct

Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follo…

2019

BACKGROUND: Scarce research has focused on Visual Memory (VM) deficits as a possible neurocognitive endophenotype of bipolar disorder (BD). The main aim of this longitudinal, family study with healthy controls was to explore whether VM dysfunction represents a neurocognitive endophenotype of BD. METHODS: Assessment of VM by Rey-Osterrieth Complex Figure Test (ROCF) was carried out on a sample of 317 subjects, including 140 patients with BD, 60 unaffected first-degree relatives (BD-Rel), and 117 genetically-unrelated healthy controls (HC), on three occasions over a 5-year period (T1, T2, and T3). BD-Rel group scores were analyzed only at T1 and T2. RESULTS: Performance of BD patients was sig…

AdultMalemedicine.medical_specialtyLongitudinal study5 year follow upClinical variablesBipolar DisorderAdolescentEndophenotypesHealth StatusDiseaseAudiologyNeuropsychological TestsFamily Study03 medical and health sciencesYoung Adult0302 clinical medicineCognitionVisual memoryMedicineLongitudinal StudyHumansBipolar disorderLongitudinal StudiesNeurocognitionAgedMemory Disordersbusiness.industryMiddle Agedmedicine.diseaseFamily study030227 psychiatryVisual MemoryPsychiatry and Mental healthClinical PsychologyEndophenotypeEndophenotypeFemaleLongitudinal studyVisual memorybusinessNeurocognitive030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Neurocognitive endophenotypes in schizophrenia and bipolar disorder: A systematic review of longitudinal family studies

2018

Although there is substantial evidence supporting the existence of neurocognitive impairment in patients diagnosed with schizophrenia (SZ) and bipolar disorder (BD), few studies have explored the field from an endophenotypic perspective. The present systematic review sought to identify longitudinal family studies exploring suitable neurocognitive endophenotypes in unaffected relatives of patients with SZ and/or BD. Following the PRISMA statement, only five follow-up studies met the inclusion criteria, comprising 79 SZ patients, 159 SZ unaffected relatives of SZ, 131 BD patients, 77 unaffected relatives of BD, and 248 controls. Verbal memory, auditory attention, face memory and emotion proce…

Bipolar DisorderEndophenotypesEmotional processing03 medical and health sciencesFamily studies0302 clinical medicinemedicineHumansCognitive DysfunctionFamilyIn patientLongitudinal StudiesBipolar disorderBiological Psychiatrybusiness.industrymedicine.disease030227 psychiatryPsychiatry and Mental healthSchizophreniaEndophenotypeSchizophreniaVerbal memorybusinessNeurocognitive030217 neurology & neurosurgeryClinical psychologySchizophrenia Research
researchProduct

Motor speed predicts stability of cognitive deficits in both schizophrenic and bipolar I patients at one-year follow-up

2009

Background We examined whether motor speed assessed by the finger tapping test predicts generalized and specific stable deficits because of a common patho-genic process in bipolar and schizophrenic patients. Methods: One hundred and two patients underwent a battery of neuropsychological tests. Patients with a score of less than one standard deviation from their siblings' sample in two assessments with an interval of one year were defined as suffering from stable deficits because of a common pathogenic process. In addition to univariate analyses, factor analyses, ordinal logistic regression, and multiple linear regressions were used. A general score was also calculated. Results: No differenc…

Psychomotor learningmedicine.medical_specialtyNeuropsychologyCognitionAudiologymedicine.diseasePsychiatry and Mental healthSchizophreniamedicineVerbal fluency testBipolar disordermedicine.symptomVerbal memoryPsychologyPsychiatryCognitive deficitThe European Journal of Psychiatry
researchProduct

Functional impairment and previous suicide attempts in bipolar disorder

2008

Objective:The aim of the present study was to assess the association between previous suicide attempts and functional impairment among euthymic patients with bipolar disorder (BD).Methods:Seventy-one Diagnostic Statistical Manual IV (DSM-IV) patients with BD and 61 healthy volunteers were recruited from the Bipolar Disorder Program at the Clinic Hospital of Barcelona. Patients with (n = 36, 50.7%) and without (n = 35, 49.3%) previous suicide attempts were assessed using the Structured Clinical Interview for DSM-IV-TR (SCID-P). Previous suicide attempts were carefully investigated by means of patient and caregiver interview and by a standard structured interview from the protocol of our BD P…

medicine.medical_specialtyPoison controlmedicine.diseaseComorbiditySuicide preventionOccupational safety and healthPsychiatry and Mental healthInjury preventionStructured interviewmedicineBipolar disorderFamily historyPsychologyPsychiatryBiological PsychiatryClinical psychologyActa Neuropsychiatrica
researchProduct

Neurocognition in bipolar disorders—A closer look at comorbidities and medications

2010

The last decade has witnessed a growing interest in the neuropsychological study of bipolar disorder (BD). This chronic mood disorder is associated with persistent neurocognitive impairments even during periods of euthymia, particularly in the broad domains of attention, verbal memory and executive functions. More interestingly, cognitive dysfunction seems to predict a poorer functional outcome among BD patients and thus represents an important target for future therapies. The aetiology of cognitive dysfunction is probably multifactorial, including gene-environment interactions with potentially confounding variables as well. Drug-induced cognitive adverse effects represent an important and …

medicine.medical_specialtyBipolar disorderComorbidityLithiumAntipsychoticNeuropsychologyAnticonvulsantmedicineAnimalsHumansBipolar disorderPsychiatryPharmacologyNeuropsychologyCognitionIatrogenic effectmedicine.diseaseExecutive functionsComorbidityPharmaceutical PreparationsObservational studyVerbal memoryCognition DisordersPsychologyNeurocognitiveClinical psychologyEuropean Journal of Pharmacology
researchProduct

Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy

2020

Minimal hepatic encephalopathy (MHE) is associated with mild cognitive impairment and frailty. This study aims to identify cognitive and motor differences in cirrhotic patients with and without MHE, and the correlations between motor signs and cognitive performance. Gait, balance, hand strength and motor speed performance were evaluated in 66 cirrhotic patients (38 without and 28 with MHE, according to the Psychometric Hepatic Encephalopathy Score (PHES). Cognitive performance was measured with the Mini-Mental State Examination, Verbal Fluency Test, Aprendizaje Verbal España-Complutense Test (TAVEC), Wechsler Adult Intelligence Scale III, Hamilton Depression and Anxiety Rating Scale and Fun…

medicine.medical_specialtyCirrosi hepàticalcsh:Medicineminimal hepatic encephalopathyAprenentatge motorAudiologyArticlecognitive assessment03 medical and health sciences0302 clinical medicineRating scaleHand strengthmedicineVerbal fluency testEffects of sleep deprivation on cognitive performanceHepatic encephalopathyminimal hepatic encephalopathy; biomechanics measurements; cognitive assessmentbiomechanics measurements cognitive assessment minimal hepatic encephalopathybusiness.industrylcsh:RWechsler Adult Intelligence ScaleCognitionGeneral Medicinemedicine.diseaseAnxiety030211 gastroenterology & hepatologymedicine.symptombusinessAprenentatge Aptitud per a l' Testshuman activities030217 neurology & neurosurgerybiomechanics measurements
researchProduct

Temporal pole morphology in first-episode schizophrenia patients:

2010

Studies of the temporal pole (TP) in schizophrenia patients are not consistent. The aim of this study was to investigate morphometric anomalies of the TP in first-episode schizophrenia patients. Patients did not significantly differ from controls in the TP morphometric variables evaluated. Clinical variables were not significantly related to the TP.

medicine.medical_specialtyClinical variablesTemporal poleSchizophrenia (object-oriented programming)Neuroscience (miscellaneous)First episode schizophreniabehavioral disciplines and activitiesPsychiatry and Mental healthmental disordersmedicineRadiology Nuclear Medicine and imagingPsychiatryPsychologyClinical psychologyPsychiatry Research: Neuroimaging
researchProduct

Additional file 2: of Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity diso…

2017

Key terms for PubMed/MEDLINE search. (DOCX 20 kb)

3. Good health
researchProduct

Improving transparency of scientific reporting to increase value and reduce waste in mental health research.

2015

Clinical Trials as TopicBiomedical Researchbusiness.industryMental DisordersGeneral MedicinePublic relationsEnvironmental economicsMental healthTransparency (behavior)030227 psychiatry03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineResearch DesignMedicineHumans030212 general & internal medicinebusinessScientific reportingRevista de psiquiatria y salud mental
researchProduct

No paradox, no progress: inverse cancer comorbidity in people with other complex diseases.

2011

Salvador Martínez [et al.]. 5 p., 2 tables and references.

medicine.medical_specialtyDown syndromeAnorexia NervosaNeuregulin-1DiseaseComorbidity03 medical and health sciences0302 clinical medicineAlzheimer DiseaseNeoplasmsEpidemiologymedicineHumansGenetic Predisposition to DiseasePsychiatryComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciencesbusiness.industryCancerParkinson Diseasemedicine.disease[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]Comorbidity3. Good healthOncologySchizophreniaAnorexia nervosa (differential diagnoses)SchizophreniaAlzheimer's diseaseDown Syndromebusiness030217 neurology & neurosurgeryChromosomes Human Pair 8The Lancet. Oncology
researchProduct

Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors

2014

Suicide is a major cause of premature death in psychosis. Earlier stages have been associated with higher risk. However, such risk periods have not been specifically determined and risk factors for suicidal behaviour may change over those periods, which may have crucial implications for suicide prevention. The aim of this study was to determine and characterize the highest risk period for suicide in a representative sample of first-episode psychosis (FEP) patients. Suicidal behaviour prior to first presentation of psychosis and during a 3-year follow-up was examined in a sample of 397 individuals. Risk factors for suicidal behaviour during specific time periods were investigated and compare…

AdultMalePsychosismedicine.medical_specialtyAdolescentSpecific riskPoison controlNeuropsychological TestsSuicide preventionYoung AdultCognitionmedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryPsychiatric Status Rating ScalesPharmacologyFirst episodeSuicide attemptMiddle Agedmedicine.diseaseSurvival AnalysisSuicidePsychiatry and Mental healthPsychotic DisordersNeurologySchizophreniaRegression AnalysisAnxietyFemaleNeurology (clinical)medicine.symptomPsychologySelf-Injurious BehaviorClinical psychologyEuropean Neuropsychopharmacology
researchProduct

MOESM4 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 4. List of PMID for included articles.

Data_FILESGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)3. Good health
researchProduct

Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain…

2005

Both neural development and prefrontal cortex function are known to be abnormal in schizophrenia and bipolar disorder. In order to test the hypothesis that these features may be related with genes that regulate neuronal migration, we analyzed two genomic regions: the lissencephaly critical region (chromosome 17p) encompassing the LIS1 gene and which is involved in human lissencephaly; and the genes related to the platelet-activating-factor, functionally related to LIS1, in 52 schizophrenic patients, 36 bipolar I patients and 65 normal control subjects. In addition, all patients and the 25 control subjects completed a neuropsychological battery. Thirteen (14.8%) patients showed genetic varia…

AdultMalePsychosisBipolar DisorderAdolescentLissencephalyNeuropsychological TestsCognitionCell MovementPredictive Value of TestsmedicineHumansBipolar disorderPlatelet Activating FactorPrefrontal cortexMolecular BiologyNeuronsAnalysis of VarianceReverse Transcriptase Polymerase Chain ReactionGeneral NeuroscienceMiddle Agedmedicine.diseaseLogistic ModelsSpainSchizophreniaEndophenotype1-Alkyl-2-acetylglycerophosphocholine EsteraseSchizophreniaFemaleAnalysis of variancePsychologyMicrotubule-Associated ProteinsNeuroscienceNeural developmentChromosomes Human Pair 17Neuroscience
researchProduct

A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's Disease, Glioblastoma and Lung cancer.

2017

Epidemiological studies indicate that patients suffering from Alzheimer’s disease have a lower risk of developing lung cancer, and suggest a higher risk of developing glioblastoma. Here we explore the molecular scenarios that might underlie direct and inverse co-morbidities between these diseases. Transcriptomic meta-analyses reveal significant numbers of genes with inverse patterns of expression in Alzheimer’s disease and lung cancer, and with similar patterns of expression in Alzheimer’s disease and glioblastoma. These observations support the existence of molecular substrates that could at least partially account for these direct and inverse co-morbidity relationships. A functional analy…

0301 basic medicineLung NeoplasmsMolecular biology[SDV]Life Sciences [q-bio]Gene ExpressionDiseaseCàncer--Fisiologia patològicaComorbidityTranscriptomeMedicineDinàmica molecularMultidisciplinaryQLung Cancer:Enginyeria biomèdica [Àrees temàtiques de la UPC]R3. Good healthAlzheimer's disease (AD)MedicineDisease SusceptibilityAlzheimer's diseaseSignal transductionSignal TransductionCentral Nervous System (CNS)ScienceModels BiologicalArticle03 medical and health sciencesImmune systemcáncerAlzheimer DiseaseDementia[CHIM]Chemical SciencesHumansLung cancerbusiness.industryGenetic Variationmedicine.diseaseComorbidityCNS cancerAlzheimer Malaltia d'030104 developmental biologyGliobastomas (GBM)ImmunologyCancer researchDementiabusinessGlioblastomaReactive Oxygen SpeciesNon-small-cell lung cancerBiomarkers
researchProduct

Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands.

2016

Dysfunctions of MeCP2 protein lead to various neurological disorders such as Rett syndrome and Autism. The exact functions of MeCP2 protein is still far from clear. At a molecular level, there exist contradictory data. MeCP2 protein is considered a single immunoreactive band around 75 kDa by western-blot analysis but several reports have revealed the existence of multiple MeCP2 immunoreactive bands above and below the level where MeCP2 is expected. MeCP2 immunoreactive bands have been interpreted in different ways. Some researchers suggest that multiple MeCP2 immunoreactive bands are unidentified proteins that cross-react with the MeCP2 antibody or degradation product of MeCP2, while others…

0301 basic medicineThreonineHeredityMethyl-CpG-Binding Protein 2Genetic LinkageMutantFluorescent Antibody TechniqueSocial Scienceslcsh:MedicinePC12 CellsBiochemistryEpitopeImmunoenzyme TechniquesCell FusionNeuroblastomaFluorescence MicroscopyAnimal CellsMedicine and Health SciencesPsychologyPost-Translational ModificationPhosphorylationAmino Acidslcsh:ScienceCells CulturedCross ReactivityNeuronsStainingMicroscopyMultidisciplinaryReverse Transcriptase Polymerase Chain ReactionOrganic CompoundsCell StainingLight MicroscopyTransfectionChemistryX-Linked TraitsSex LinkagePhysical SciencesCellular TypesResearch ArticleCell signalingCell Physiologycongenital hereditary and neonatal diseases and abnormalitiesBlotting WesternImmunologyRett syndromeBiologyReal-Time Polymerase Chain ReactionResearch and Analysis MethodsMECP203 medical and health sciencesNeurologiaAntigenHydroxyl Amino Acidsmental disordersmedicineRett SyndromeGeneticsAnimalsHumansRNA MessengerClinical GeneticsHEK 293 cellsOrganic Chemistrylcsh:RChemical CompoundsBiology and Life SciencesProteinsCell Biologymedicine.diseaseMolecular biologyRatsnervous system diseases030104 developmental biologyHEK293 CellsSpecimen Preparation and TreatmentCellular NeuroscienceMutationDevelopmental PsychologyMalaltieslcsh:QNeuroscience
researchProduct

Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.

2013

This randomized open-label study compared the incidence of metabolic side effects of aripiprazole, ziprasidone and quetiapine in a population of medication-naive first-episode psychosis patients. A total of 202 subjects were enrolled. Body weight, body mass index, leptin, fasting lipids and fasting glycaemic parameters were measured at baseline and at 3 months follow-up. A hundred and sixty-six patients completed the follow-up and were included in the analyses. A high proportion of patients experienced a significant weight increase (>7% of their baseline weight): 23% ziprasidone (n=12), 32% with quetiapine (n=16) and 45% with aripiprazole (n=31). Patients treated with aripiprazole gained si…

AdultMalemedicine.medical_specialtyPsychosisDibenzothiazepinesPopulationAripiprazoleQuinolonesWeight GainGastroenterologyPiperazinesQuetiapine FumarateSex FactorsInternal medicinemedicineHumansZiprasidoneeducationPsychiatryBiological Psychiatryeducation.field_of_studybusiness.industryLeptinmedicine.diseaseProlactinPsychiatry and Mental healthThiazolesCholesterolPsychotic DisordersQuetiapineAripiprazoleFemalemedicine.symptombusinessWeight gainBody mass indexmedicine.drugAntipsychotic AgentsFollow-Up StudiesSchizophrenia research
researchProduct

MOESM3 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 3. Reporting checklist.

3. Good health
researchProduct

Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.

2011

Abstract Background Different factors may influence cognitive functioning in bipolar disorder such as the effect of subsyndromal symptoms, the history of psychotic symptomatology or substance abuse, negative symptomatology, chronicity, sleep disturbances, and hormonal factors. The effect of pharmacologic treatment on cognition is still uncertain because of an insufficient number of studies examining this issue. Objective The aims of this study were to compare neuropsychologic performance of treated bipolar patients with that of controls, including unmedicated patients and healthy subjects, as well as to evaluate possible neurocognitive differences among 3 different atypical antipsychotics. …

OlanzapineAdultMalemedicine.medical_specialtyDibenzothiazepinesBipolar DisorderAdolescentlcsh:RC435-571medicine.drug_classmedicine.medical_treatmentEmotionsAtypical antipsychoticNeuropsychological TestsYoung Mania Rating ScaleBenzodiazepinesExecutive FunctionQuetiapine FumarateYoung AdultCognitionMemorylcsh:PsychiatrymedicineHumansAttentionBipolar disorderPsychiatryAntipsychoticPsychiatric Status Rating ScalesRisperidoneCalifornia Verbal Learning TestMiddle Agedmedicine.diseaseRisperidonePsychiatry and Mental healthClinical PsychologyOlanzapineCase-Control StudiesQuetiapineFemalePsychologymedicine.drugClinical psychologyAntipsychotic AgentsComprehensive psychiatry
researchProduct

Lifestyle changes and mental health during the COVID-19 pandemic: A repeated, cross-sectional web survey

2021

VBM acknowledges the national grant PI16/01770 from the Instituto de Salud Carlos III, ISCIII (The PROBILIFE study). EV thanks the support of the Spanish Ministry of Science and Innovation (PI15/00283, PI18/00805) integrated into the Plan Nacional de I+D+I and co-financed by the ISCIII-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER); the Instituto de Salud Carlos III; the CIBER of Mental Health (CIBERSAM) (...)

Web surveyLifestyle Mental healthPopulationAlcohol abuseAnxietyExternal validitySocial supportSelf-rated healthSurveys and QuestionnairesPandemicLockdownmedicineHumansLife StylePandemicsExerciseDepression (differential diagnoses)PsychiatryResiliencebusiness.industrySARS-CoV-2DepressionPreventionCOVID-19General populationmedicine.diseaseLifestyleMental healthPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesMental HealthScale (social sciences)Communicable Disease ControlAnxietymedicine.symptombusinessSleepDemographyResearch Paper
researchProduct

Predictors of functional outcome after a manic episode.

2015

Abstract Background The identification of functional outcome predictors after acute episodes of bipolar disorders (BD) may allow designing appropriate treatment aiming at restoring psychosocial functioning. Our objective was to identify the best functional outcome predictors at a 6-month follow-up after an index manic episode. Methods We conducted a naturalistic trial (MANACOR) focusing on the global burden of BD, with special emphasis on manic episode-associated costs. We observed patients with BD seen in services of four hospitals in Catalonia (Spain).The total sample included 169 patients with chronic DSM-IV-TR BD I suffering from an acute manic episode who were followed-up for 6 months.…

AdultMalemedicine.medical_specialtyBipolar DisorderBody Mass IndexRecurrenceInternal medicinemedicineHumansBipolar disorderPsychiatryRetrospective StudiesStepwise regressionmedicine.diseaseOutcome (probability)Psychiatry and Mental healthClinical PsychologyTreatment OutcomeSocioeconomic FactorsSpainTreatment strategyFemalePredictive variablesPsychologyPsychosocialBody mass indexFollow-Up StudiesJournal of affective disorders
researchProduct

Mutations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar disorder: a preliminary study

2006

El artículo se basa en la presentación de un póster en International Society on Brain and Behaviour: 2nd International Congress on Brain and Behaviour Thessaloniki, Greece. 17–20 November 2005

medicine.medical_specialtylcsh:RC435-571educationNeuronal migrationCognitionmedicine.diseasePsychiatry and Mental healthSchizophreniaInternational congressForensic psychiatrylcsh:Psychiatrymental disordersmedicineBipolar disorderPsychopharmacologyPsychiatryPsychologyGeriatric psychiatryhealth care economics and organizations
researchProduct

Five Interpersonal Factors Are Predictive of the Response to Treatment of Major Depression With Antidepressants in Primary Care

2018

Introduction: Factors relating to the interpersonal relationship between the patient and their physician and social environment are important components, which contribute to their response to treatment for major depressive disorder. This study aimed to assess the influence of optimism, perfectionism, therapeutic alliance, empathy, social support, and adherence to medication regimen in the response to antidepressant treatments in the context of normal primary care clinical practice.Method: We conducted a prospective study in which 24 primary care physicians administered sertraline or escitalopram to 89 patients diagnosed with major depressive disorder. The response to treatment and remission…

medicine.medical_specialtylcsh:RC435-571psiquiatriaContext (language use)malalties mentals03 medical and health sciencesSocial supportprimary care0302 clinical medicinelcsh:PsychiatryInternal medicineMedicineEscitalopram030212 general & internal medicineProspective cohort studyempathyOriginal ResearchPsychiatrySertralinebusiness.industrytherapeutic alliancePrimary care physicianSocial environmentsocial supportmedicine.diseaseoptimismPsychiatry and Mental healthantidepressantsMajor depressive disorderperfectionismbusiness030217 neurology & neurosurgerymedicine.drugFrontiers in Psychiatry
researchProduct

Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects.

2007

Objective:  Only a few studies have examined specifically the neuropsychological performance of schizoaffective patients. Method:  The sample consisted of 34 euthymic DSM-IV schizoaffective patients, who were compared with 41 euthymic bipolar patients without history of psychotic symptoms and 35 healthy controls. Euthymia was defined by a score of 6 or less at the Young Mania Rating Scale and a score of 8 or less at the Hamilton Depression Rating Scale for at least 6 months. Patients were compared with several clinical, occupational, and neuropsychological variables such as executive function, attention, verbal and visual memory and the two groups were contrasted with 35 healthy controls on…

AdultMalePsychosismedicine.medical_specialtyBipolar DisorderHealth StatusSchizoaffective disorderNeuropsychological TestsYoung Mania Rating ScaleSeverity of Illness IndexSurveys and QuestionnairesmedicineVerbal fluency testHumansBipolar disorderPsychiatryDemographyCognitive disorderBrainmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesPsychotic DisordersFemaleVerbal memoryPsychologyCognition DisordersNeurocognitiveClinical psychologyActa psychiatrica Scandinavica
researchProduct

Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-a…

2019

© The Author(s) 2019.

medicine.medical_specialtyEpidemiological studyPopulationMEDLINElcsh:MedicineMedicine (miscellaneous)ComorbidityPsycINFOImpulsivityAttention deficit hyperactivity disorder03 medical and health sciences0302 clinical medicineMeta-Analysis as Topicmental disordersProtocolPrevalencemedicineHumansAttention deficit hyperactivity disorder030212 general & internal medicineeducationPsychiatryeducation.field_of_studybusiness.industry030503 health policy & serviceslcsh:Rmedicine.diseaseComorbidityObservational Studies as TopicMeta-analysisCross-Sectional StudiesAttention Deficit Disorder with HyperactivityResearch DesignSpainMeta-analysisSystematic reviewObservational studymedicine.symptom0305 other medical sciencebusinessSystematic Reviews as TopicSystematic Reviews
researchProduct

MOESM5 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 5. List of excluded articles.

Data_FILESTheoryofComputation_GENERALGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)3. Good health
researchProduct

Additional file 5: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full differential gene expression meta-analysis results of cancer data. (ZIP 31237 kb)

population characteristicshuman activities
researchProduct

Additional file 3: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full ASD GSEA pre-ranked enrichment results for different molecular signatures (C2, H, GO_BP, GO_CC, and GO_MF). (XLSX 698 kb)

researchProduct

Additional file 5: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full differential gene expression meta-analysis results of cancer data. (ZIP 31237 kb)

population characteristicshuman activities
researchProduct

Additional file 3: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full ASD GSEA pre-ranked enrichment results for different molecular signatures (C2, H, GO_BP, GO_CC, and GO_MF). (XLSX 698 kb)

researchProduct

Additional file 4: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

gProfileR biological process overrepresentation results of the genes contained in the significant intersections of ASD, SDDCs, and ODDCs. (XLSX 233 kb)

researchProduct

Additional file 2: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full ASD differential gene expression meta-analysis results. (CSV 1387 kb)

researchProduct

Additional file 2: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full ASD differential gene expression meta-analysis results. (CSV 1387 kb)

researchProduct

Additional file 4: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

gProfileR biological process overrepresentation results of the genes contained in the significant intersections of ASD, SDDCs, and ODDCs. (XLSX 233 kb)

researchProduct